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Abstract 
The FGF signal transduction pathway has been linked to many events that occur 
throughout vertebrate development. Model systems,·such as the amphibian Xenopus 
laevis, have been used to define numerous components of this signalling cascade. One 
such discovery was Xmi-er 1, a maternally derived immediate-early gene in the FGF 
pathway thought to act in transcriptional regulation. The purpose of this project was to 
further characterize the activity ofXMI-ERI in the developing Xenopus embryo and to 
explore how this activity relates to its molecular structure. 
Over-expression of Xmi-er1 resulted in truncations along the anteroposterior axis. 
These abnormalities first become apparent during gastrulation. Analysis of tissue 
development using antibodies demonstrated that both mesodermal and neural tissues are 
affected by Xmi-er 1 over-expression, yet differentiation still occurs in the most severe 
cases. In FGF-induced mesoderm induction, this event was partially inhibited in the 
presence of excess XMI-ERl. No analogous inhibition was observed with mesoderm 
induction by activin. Also suppressed was part of the expression pattern of the early 
mesodermal marker, brachyury. Subsequent examination of the various domains present 
in the protein implicated a proline-rich region in the over-expression activities ofXMI-
ERI throughout development, however the investigation failed to connect both the SANT 
domain and the ELM2 domain to this effect. Overall, these results indicate that XMI-
ERI functions in some FGF-related cellular activities, such as mesoderm induction, but 
11 
that its role may not be limited to this pathway. This function appears to be dependent 
upon the proline-rich region. 
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Chapter 1: Introduction 
1.1 Xenopus laevis as a model system 
Embryos from the amphibian Xenopus laevis, also known as the African Clawed 
Frog, have been used in the laboratory as a model system for decades. They were 
initially employed as a pregnancy test for women, although in recent years their primary 
use has been in the study of developmental mechanisms in vertebrates. There are a 
number of reasons why this species is preferred for such studies. One main advantage is 
the fact that the eggs develop outside of the female .. This means that not only are they 
easily accessible to the researcher, but because development is external the presence of 
yolk in the egg is essential, causing the eggs themselves to be quite large in size (Jones & 
Smith, 1995). This makes them very easy to handle and manipulate. A second benefit is 
that the eggs are relatively simple to obtain at all times of the year, even in comparison 
with other amphibian species. This is accomplished by the injection of the hormone 
human chorionic gonadotrophin, or HCG. As well, the adult frogs are quite robust and 
often thrive in the laboratory setting. 
The rapid development of the embryos into tadpoles is another advantage. Many 
researchers use this quality to investigate the function of a particular gene during 
development. This can be done by injecting a recently fertilized egg with a small amount 
of mRNA, letting the embryo develop, and then observing the tadpole for any effects the 
over-expressed gene may have had on its growth and development. As well, loss-of-
function studies with this species are now becoming quite common in order to examine 
1 
the opposite scenario. This is accomplished through new techniques such as morpholino 
antisense oligonucleotides and RNA interference (RNAi). Studies such as these have 
revealed an increasingly intricate array of cellular and molecular interactions that are 
necessary for the proper development of eggs into tadpoles and ultimately viable adults. 
Therefore, the importance of X laevis to the evolution of developmental biology has been 
tremendous. 
1.2 Early development of X laevis 
During the development stages of X laevis, the fertilized egg grows from a single 
cell into a complex organism (Figure 1.1) With many different tissue types and a defined 
body plan. The method by which this is achieved has been the focus of much 
investigation. It is now thought that this early development is characterized by three 
major steps: (1) the establishment of the dorsoventral axis; (2) the designation of the 
three prospective germ layers; and, (3) the various movements involved in gastrulation 
(Kuhl, 2002). 
The first of these steps occurs soon after fertilization. When the eggs are initially 
laid, they are polarized along the animal-vegetal axis. The animal half or hemisphere is 
darkly pigmented, while the vegetal hemisphere is unpigmented. At this point the eggs 
possess a random orientation with respect to gravity and there is no indication of the 
dorsoventral axis. The sperm can enter the egg at any point in the animal hemisphere. 
Once it does, the egg undergoes cortical granule release. Cortical granules are 
membrane-bound structures containing enzymes and proteins that are located in a layer 
2 
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tadpole 1' 
\ 36 hr Xenopus 
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. 
' 
late tailbud ~8 hr 
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Figure 1.1 The lifecycle of X laevis 
3 hr ..V 
Ala 
\Ecb11 
7 hr V, blastula 
The above diagram demonstrates the entire lifecycle of X laevis from a single-celled egg 
all the way to a tadpole and then an adult. Reproduced from: 
http://www .xenbase.org/intro .html. 
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directly beneath the plasma membrane. The cortical granule release enables the egg to 
rotate such that the denser vegetal hemisphere is down. During this process, the granules 
fuse with the plasma membrane and release their contents into the space between the egg 
. 
and the vitelline membrane surrounding it. This is a protective membrane forming a 
fibrous mat around the egg that is essential for species-specific sperm binding and for the 
prevention of polyspermy. 
Soon after this event, the cytoplasm undergoes a rearrangement as well based on 
the location of the sperm entry point, or SEP, as shown in Figure 1.2. The cortical or 
outer layer of cytoplasm shifts by approximately 30° toward the SEP (Manes & Elinson, 
1980; Vincent eta/., 1986), driven by a parallel array of micro tubules that lies between 
the cortical and inner cytoplasm in the vegetal hemisphere (Elinson & Rowning, 1988). 
These microtubules are thought to provide tracks that allow the cortex to move. This 
movement ultimately defines the future dorsoventral axis of the embryo, with the side 
opposite the SEP being dorsal. The newly established dorsal vegetal region encompasses 
a signalling centre named after the famous embryologist, Peter Nieuwkoop. It is 
therefore often referred to as the Nieuwkoop centre and provides a dorsalizing signal to 
be discussed in further detail later (reviewed in Harland & Gerhart, 1997; Jones & Smith, 
1995). 
During the early cleavage stages that follow fertilization, the embryo goes from a 
single cell to a multi-cellular organism in a remarkably short amount oftime. Maternally 
derived stores of mRNA and protein regulate this process until stage 8 according to 
Nieuwkoop (1994). These maternal cytoplasmic determinants are asymmetrically 
4 
Figure 1.2 Cross section of the egg during cortical rotation 
The two hemispheres of the egg are indicated as animal, A, and vegetal, V. The sperm 
entry point, or SEP, is highlighted in the animal hemisphere on the left. Once the egg is 
fertilized, microtubules align and the cortex located opposite the SEP rotates 30° in the 
direction of the arrow at the bottom right. Adapted from Harland & Gerhart (1997). 
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arranged throughout the embryo and this, together with cell-cell signalling, defmes 
development throughout these early stages (McDowell & Gurdon, 1999). 
The first cell cycle takes approximately 90 minutes, and the fust cleavage, 
occurring at the end of this cycle, usually passes through the SEP and separates the 
prospective right and left sides of the embryo. Subsequent divisions generally require 
only 30 minutes to complete, with the second one also occurring along the animal-vegetal 
axis perpendicular to the first. This divides the future dorsal and ventral poles in the 
embryo and these can often be identified by the slightly smaller size of the dorsal cells or 
blastomeres. The third cleavage occurs in the equatorial region at a right angle to the first 
two divisions, and separates the animal and vegetal hemispheres. As these cleavages 
proceed, a small space forms inside the developing embryo that ultimately becomes the 
blastocoel, a large cavity significant during the blastula stages of development (Jones & 
Smith, 1995). 
From stage 6.5 to 9 the embryo is referred to as a blastula. During this step, the 
embryo grows from a single to a double layer of cells. By cell cycle 13, corresponding to 
stage 8 of development according to Nieuwkoop (1994), an event known as the mid-
blastula transition (MBT) occurs (Newport & Kirchner, 1982). At this time, the 
previously synchronous pattern of rapid divisions slows down and shifts to an 
asynchronous one. As well, it is at this point in development that zygotic transcription 
and cell motility begins (Newport & Kirschner, 1984). 
The next phase is gastrulation, in which the hollow blastula becomes a three-
layered structure. This phase encompasses the aforementioned steps 2 and 3 of early X 
6 
laevis development. Gastrulation is characterized by a series of movements, as the 
prospective endoderm cells move inward at the dorsal side of the vegetal pole forming a 
visible structure known as the dorsal lip. This activity extends laterally, and, as more 
cells follow in this movement, the lip grows frrst into an arc and eventually into a full 
circle. Meanwhile, some of the prospective mesoderm cells that have recently been 
specified inside the embryo begin to migrate along the blastocoel roof at the dorsal 
region. The remaining mesodermal cells eventually join in with this movement by a 
process of convergent extension. That is, the cells intercalate causing the tissue to narrow 
and at the same time they move forward. As these movements continue, the outside of 
the embryo becomes completely surrounded by the cells of the animal hemisphere, which 
will eventually form the ectoderm. By the end of gastrulation, the three layers have 
reached their desired positions within the embryo. Underneath the outer ectoderm layer 
now lies the mesoderm, and beneath this is the endoderm. In this way, the three germ 
layers are established and organized, thus completing steps 2 and 3 of the development 
process. 
With respect to the outcome of these germ layers, fate maps of the embryo at 
various stages of development provide a clear picture of the structures that develop from 
each tissue. Knowledge of the fates of these cells during normal development enables 
researchers to investigate abnormal development, especially when the abnormality is 
caused by the intentional over- or under-expression of a particular gene. These fate maps 
demonstrate that the ectoderm eventually becomes the epidermis and nervous system. 
The mesoderm forms the notochord, the somites, the urinary system, and the genital 
7 
ducts. Parts of it also develop into the heart, blood vessels and cells, as well as some 
tissue in the head. As well, the endoderm ultimately forms the lining of the digestive and 
respiratory tubes along with their respective organs. 
Following gastrulation is the formation of the neural tube during neurulation, 
involving yet another set of intricate movements. The neural plate undergoes convergent 
extension in a manner similar to the mesoderm during the previous stage. Later on, the 
neural tube forms from the dorsal ectoderm. Also beginning in this phase and continuing 
after it, the mesoderm differentiates irito various tissues along the dorsoventral axis. 
These events ultimately result in the formation of a complete tadpole. For a summary of 
the lifecycle of X laevis, refer to Figure 1.1. 
1.3 X laevis patterning and mesoderm induction 
Cells of the early embryo are considered to be pluripotent. That is, they can 
develop into different tissues depending on their environment. However, as development 
progresses, cells eventually lose the ability l:o differentiate into alternate cell types and in 
this way they become committed to one particular fate. This fate results largely from 
cellular interactions within the early embryo. It is these interactions, which occurs both 
between cells and between tissues, that ultimately pattern the organism (Chang & 
. Hemmati-Brivanlou, 1998). With respect to the X laevis embryo, the full range of 
processes involved in its patterning are not completely understood. Nevertheless, 
advances made in the past few years have clarified many uncertainties regarding this 
complex event. 
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When the egg is first laid, differences already exist along the animal-vegetal axis. 
Maternally derived proteins are thought to be precisely localized within the egg at this 
time. The patterning events that follow elaborate upon this initial arrangement. The first 
of these begins in the early embryo soon after fertilization. During cortical rotation, the 
cortex of the egg rotates 30° with respect to the inner cytoplasm. Also at this time, a set 
of organelles in the vegetal pole moves 60-90° to the prospective dorsal side of the 
embryo (Rowning eta/., 1997). These events are thought to distribute a dorsal 
determinant to the side of the egg opposite sperm entry (i.e., the Nieuwkoop centre), 
ensuring that dorsal structures develop from this area. Evidence indicates that this 
determinant moves from the vegetal pole to the future dorsal side, and that its activity is 
transplantable (Moon & Kimelman, 1998). This is the first major patterning event that 
occurs in the embryo. Stemming directly from this organizational event is a second one 
that establishes the future mesoderm of the frog. This is known as mesoderm induction. 
The process of mesoderm induction was first described by Pieter Nieuwkoop in 
1969. In one of his most famous experiments, he joined parts of the animal cap together 
with explants from the vegetal pole and was able to induce the animal cap cells to form 
mesoderm instead of ectoderm, which is what would normally arise if these cells were 
left in isolation (Nieuwkoop, 1969). It is now well known that in X laevis the mesoderm 
develops from the ring of cells located along the equatorial region of the blastula. The 
specification of the cells in this region occurs during the cleavage divisions such that by 
the mid-blastula transition, at approximately the 4000-cell stage, many of the mesoderm-
specific genes in these cells are already turned on (Harland & Gerhart, 1997). 
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During the early stages of development, the embryo consists of only two cell 
types - the prospective ectoderm in the animal pole and the prospective endoderm in the 
vegetal pole. Mesoderm induction does not begin until the 64-cell stage (Smith, 1993) 
and involves signals originating from the cells in the vegetal pole of the embryo. In 
general, there are many differing views on how mesodermal patterning takes place, 
however three important trains of thought have developed over the years. In the frrst and 
earliest view that is derived from the aforementioned experiment by Nieuwkoop, the 
mesoderm and head endoderm are believed to be formed by the interaction between the 
cells of the animal hemisphere with those of the vegetal pole. This view holds that the 
signal produced by the vegetal cells forms a gradient from the dorsal to the ventral side 
thus enabling the induction of different types of mesoderm along the equatorial region 
(Harland & Gerhart, 1997). 
The second view was the 'three-signal' model for mesoderm formation put forth 
by Smith and Slack (1983) (Figure 1.3). This model proposed that early cytoplasmic 
rearrangements cause two inductive centres to be established ~ithin the vegetal 
hemisphere of the X laevis embryo - one located in the dorsal region and one in the 
ventral. Later on during the blastula stages, the dorso-vegetal cells induce the overlying 
cells in the marginal zone to form a region known as the organizer, while the ventro-
vegetal cells induce the formation of ventral mesoderm also in the overlying marginal 
zone. It is the organizer that then produces the third signal referred to in this model. This 
does not occur until gastrulation (Harland & Gerhart, 1997) at which point it has a 
dorsalizing effect on the adjacent mesoderm and induces it to form intermediate 
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mesoderm (Smith & Slack, 1983; Dale et al., 1985). The ability of these cells to 
'organize' embryonic development was discovered through the early work of Spemann 
and Mangold (Harland & Gerhart, 1997). For this reason, the organizer is often referred 
to as the 'Spemann Organizer'. 
In the current model, which has superseded the previous two, the body plan is 
thought to be organized by two maternal determinants present in the early embryo, one 
that controls mesoderm/endoderm development and a second that regulates dorsal 
development (Heasman, 1997). The latter event involves signalling through the Wnt/J3-
catenin pathway (Harland & Gerhart, 1997), while the former is regulated by the T -box 
transcription factor, VegT (Zhang et al., 1998; Kofron et al., 1999). This molecule has 
been found to be localized to the vegetal cortex of the oocyte and its presence leads to the 
expression of mesoderm inducers, which in tum signal the development of mesoderm in 
the marginal zone after MBT (reviewed in Kimelman & Griffin, 2000). The signalling 
events that power primary germ layer formation and dorsalization act through 
overlapping yet distinct signalling pathways (Lee et al., 2001 ). 
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Animal 
Figure 1.3 The three-signal model of mesoderm induction 
In the early embryo, the vegetal hemisphere is divided into the ventro-vegetal (VV) and 
the dorso-vegetal (DV) regions. During mesoderm induction, the VV cells induce the 
overlying marginal zone cells to form ventral mesoderm (M3), and the DV cells induce 
the equatorial cells above to form the organizer (0). The organizer then signals the 
ventral mesoderm to differentiate into lateral mesoderm (M1 and M2). Adapted from 
Dale and Slack (1987). 
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1.4 Mesoderm inducing signals 
By varying the signals produced by the vegetal blastomeres, or by changing the 
intensity of the signals or how cells respond to them, different types of mesoderm can be 
induced. Initially this induction event was thought to take place very early on in 
development, however it is now known that while these signals appear at low levels prior 
to zygotic gene transcription, they become much stronger after MBT (Zhang eta/., 1998). 
In general, the signals produced during mesoderm induction are active from the 64-cell 
stage until early gastrula. Many of these result from distinct but overlapping signal 
transduction pathways. They are the triggers thought to carry out the mesoderm 
induction models discussed previously, however the exact molecules involved have yet to 
be fully agreed upon. 
There are two problems often encountered in trying to identify potential inducers 
(Christen & Slack, 1999). The frrst is that even if the gene expression of the inducer is 
confrrmed at the mRNA level, there is no guarantee that it will be translated into protein, 
secreted, and processed in the correct manner. The second problem involves the idea of 
biological redundancy. If the factor under investigation does function as a true mesoderm 
inducer in the embryo there is still the possibility that other unidentified factors exist that 
can stimulate the same receptor or act in the same way. Nevertheless, by acknowledging 
these problems and by implementing the proper controls for them, it is still possible to 
pinpoint active inducing molecules. 
With respect to the zygotic signals, much of the data in this area stems from 
'animal cap' experiments in which an explant is taken from the prospective ectoderm of a 
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blastula stage embryo and incubated with potential inducers in an attempt to pinpoint the 
actual molecules responsible for mesoderm induction in the embryo. Although this 
method has made it relatively easy to discover proteins that can induce mesoderm from 
ectoderm in vitro, confirming the activities of these molecules in the whole embryo has 
been quite difficult. Nevertheless, through years of experimentation and debate, a few 
key signals have been identified. 
In general, there appears to be a variety of molecules involved in the process of 
mesoderm induction (Harland & Gerhart, 1997). One of the earliest known signals is 
VegT, a maternally derived T -box transcription factor localized in the vegetal 
hemisphere. This factor is responsible for activating the zygotic signals that regulate 
mesoderm induction (Zhang et al., 1998) and comprises the early low-level mesoderm 
induction signal mentioned earlier. VegT is known to activate several members of the 
transforming growth factor f3 (TGFf3) superfamily, including a number of nodal-related 
genes. These signals appear to be active during the cleavage and blastula stages of 
embryogenesis. Bone morphogenic proteins (BMPs), which are a subgroup ofTGFf3-like 
molecules, function in the specification of ventral character in the mesoderm during 
gastrulation (Heasman, 1997). On the other hand, f3-catenin has a dorsalizing effect 
during development and appears to be involved in regulating the expression of some 
mesodermal genes (Vonica & Gumbiner, 2002), while fibroblast growth factors (FGFs) 
are required for mesodermal maintenance (Isaacs eta/., 1994) and competence (Cornell 
eta/., 1995). 
The involvement of the TGFf3 pathway in mesoderm induction has been 
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confirmed by experiments involving a dominant negative TGFf3 family receptor, as 
mesoderm formation is inhibited in embryos expressing this inactive receptor (Hemmati-
Brivanlou & Melton, 1992). Members of this family that are thought to be involved in 
mesoderm induction include Derriere, and the nodal related genes Xnr 1, Xnr 2, and Xnr4, 
-5, and -6 (Jones eta/., 1995; Joseph & Melton, 1997; Sun eta/., 1999; Takahashi eta/., 
2000). These genes are expressed at the right time and place in the embryo to act as 
endogenous inducers (White et al., 2002)~ While the Xnrs appear to be required 
throughout the body, Derriere· may only be necessary for trunk and tail development 
(Kofron eta/., 1999; Sun et al., 1999; K.imelman & Oriffm, 2000). 
V g1 and activin, which are part of the TGFf3 family as well, are also thought to 
play a role in mesoderm induction. Activins are known to possess potent mesoderm-
inducing activity in animal cap experiments (Green & Smith, 1990). These inductions 
result in increasingly dorsal mesoderm as the concentration of activin is increased. 
Although its activity in vivo is somewhat controversial, activin has recently been found to 
be required for the induction ofboth mesoderm as well as endoderm (Lee et al., 2001). 
V g 1 is a maternally expressed protein localized to the vegetal pole of cleavage stage 
embryos (Weeks & Melton, 1987). However, it should be noted that TGFf3-related 
molecules form disulfide-linked dimers that must be cleaved to release the mature, active 
protein. For Vg1, this cleaved form has yet to be found in the early embryo suggesting 
that its activity is tightly regulated throughout development (Kessler & Melton, 1994 ). 
Nevertheless, inhibition of this molecule using dominant negative mutants causes dorsal 
mesodermal defects (Joseph & Melton, 1998). 
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Also involved in mesoderm induction are the BMPs. Several maternally derived 
mRNAs have been identified in the early embryo, including BMP2, BMP4, and BMP7, 
although their respective functions are still unclear (Heasman, 1997). These molecules 
are thought to be involved in the specification of ventral mesoderm as activation of their 
signalling pathways in the mesoderm assigns a ventral character to this tissue (Dale eta/., 
1992). In mesoderm induction assays, BMP4 has been found to induce ventral 
mesodermal tissues (Dale eta/., 1992; Kessler & Melton, 1994). Likewise, interference 
with the BMP signal inhibits the development of ventral mesoderm (Maeno eta/., 1994). 
While the in vivo involvement ofBMPs in mesoderm induction has yet to be confrrmed, 
the machinery for their pathway is well in place by the time this process begins, making 
them good candidates for mesoderm inducers (Eimon & Harland, 1999). 
With respect to dorsal specification, f3-catenin is a key determinant. It is the 
principle downstream target of the Wnt-1 signalling pathway and functions as a 
transcription factor once activated. Its levels are regulated by the upstream serine-
threonine kinase known as glycogen synthase kinase, or GSK3 (Moon & Kimelman, 
1998). f3-catenin is known to be present in the early X laevis embryo. Both over-
expression and depletion studies have implicated this as a key endogenous molecule 
necessary for determining the dorsoventral axis. Interference with maternal J3-catenin 
causes embryos to develop without dorsal structures (Heasman eta/., 1994). Overall, its 
levels are increased very early on in the embryo at the prospective dorsal side opposite 
the SEP. It continues to accumulate in all cells until the 16- to 32-cell stage, at which 
point its levels only rise higher in the dorsal blastomeres. Furthermore, f3-catenin is 
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known to be involved in a complex with XTcf.:3 (Molenaar eta/., 1996), and may 
function in the activation of organizer genes, such as Siamois, during mesoderm 
induction (Moon & Kimelman, 1998). 
Of the FGFs, FGF-2 was the first to be implicated in mesoderm induction 
(Kimelman & Kirschner, 1987; Slack eta/., 1987). It was initially found to be a potent 
inducer of ventral mesoderm but later work demonstrated that FGF was involved in the 
formation of dorsal mesoderm as well (Harland & Gerhart, 1997). Much of this work 
was based upon dominant negative experiments with a mutant FGF receptor, XFD 
(discussed below), and on interference with downstream signals (Amaya et al., 1991; 
Amaya eta/., 1993). It is now thought that the FGFs act in mesodermal maintenance 
rather than induction. The FGF family of proteins and their signalling pathways will be 
discussed in greater detail in the next section. 
1.5 Fibroblast growth factors 
Many members of the fibroblast growth factor family o.f proteins are involved in 
controlling cell growth, differentiation, and movement throughout the development of X 
laevis. FGF activity has been implicated in both mesoderm formation as well as axial 
patterning. The proteins are expressed in the animal cap and marginal zone of the 
blastula stage embryo (Curran & Grainger, 2000). FGF signalling has also been shown to 
be required for mesoderm induction. In 1991, Amaya et al. found that embryos 
expressing a truncated and therefore inactive form of the FGF receptor known as XFD 
could completely abolish wild-type receptor function. Explants from these embryos 
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failed to respond to FGF to induce mesoderm and whole embryos had gastrulation 
defects and abnormal posterior development, thus implicating FGF signalling in early 
embryogenesis and in the development of posterior and lateral mesoderm (Amaya et a/., 
. 
1991). The role ofFGF signalling was examined further when Amaya et al. found that 
the XFD protein inhibits the marginal zone expression of Xenopus brachyury (Xbra), a 
known immediate-early gene for FGF, yet it fails to affect the expression of Xenopus 
goosecoid (Xgsc), which is expressed dorsally in the first mesodermal cells that involute 
during gastrulation (1993). Later, Kroll and Amaya created transgenic frogs that only 
expressed the XFD construct after MBT when much of the mesoderm in the embryo is 
already induced and found that Xbra expression is lost in the mesoderm by mid-
gastrulation and that the embryos lack a notochord and somites (1996). In this way, they 
demonstrated that FGF signalling is necessary for the maintenance of mesoderm. 
The fibroblast growth factors belong to a large family of signalling molecules 
with a wide variety of biological functions. All members of the family are known to bind 
to heparin and heparan sulphate, and were therefore originally named as heparin-binding 
growth factors. However, the nomenclature has since changed due to the fact that many 
unrelated proteins are also known to bind heparin. This attribute nonetheless continues to 
play a big role in the behaviour of these proteins. Its purpose is thought to be twofold: 
(1) to protect FGFs from degradation; and, (2) to create a local pool of available growth 
factors (Powers et al., 2000). The structural similarity between the members of the FGF 
family ranges from 40% to more than 70% amino acid sequence identity (Manetti et al., 
2000). In general, FGFs are defined by a central core of 140 amino acids that are highly 
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conserved between families (Powers eta/., 2000). Most act extracellularly through the 
activity of a high affinity receptor. Yet, three members lack the classical leader 
sequences targeting them for secretion. It is thought that these forms are transported to 
the extracellular space via an alternate mechanism (reviewed in Powers eta/., 2000). 
Overall the FGF family consists of at least 20 different polypeptides. Of these, 
seven have been shown to be active in mesoderm induction assays using animal caps 
from X laevis (reviewed in Isaacs, 1997). When investigating which proteins are active 
in the embryo during patterning, it is important to consider the presence of secretory 
signal peptides (Isaacs, 1997). FGFs both with and without these peptides are found in 
the early embryo. So far, there are a total of four FGFs that are known to be present in X 
laevis. These include basic FGF (bFGF or FGF-2), int-2 (FGF-3), embryonic FGF 
(eFGF), and FGF-9, although int-2 mRNA does not appear until after MBT (Tannahill et 
a/., 1992; Isaacs, 1997; Kimelman & Kirschner, 1987). The remaining three are therefore 
good mesoderm inducing candidates, while all four are probably involved in mesoderm 
maintenance and post-MBT patterning as they are all expressed in the mesoderm after 
MBT (Isaacs, 1997). 
Basic FGF, and the closely related acidic FGF (aFGF), were the first two FGFs to 
be identified and characterized (Gospodarowicz, 1974; Gospodarowicz eta/., 1975; 
Gospodarowicz eta/., 1986; Gospodarowicz, 1987). FGF-2 protein is present at low 
levels in the early embryo prior to the onset of zygotic transcription, indicating that it is 
maternally derived. These levels increase at mid-neurula stages when zygotic 
transcription of this gene is activated (Song & Slack, 1994). Localization during blastula 
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stages is predominantly in the animal hemisphere. This, together with the fact that it 
lacks a signal peptide and that antibodies against it fail to block mesoderm induction 
(Slack, 1991), suggest that this is not part of the mesoderm inducing signal originating 
from the vegetal pole (Isaacs, 1997). 
As discussed earlier, FGF-3 is also an unlikely candidate for the vegetal inducing 
signal as it is only expressed zygotically. FGF-9 is maternally derived, but is found in the 
animal hemisphere of the early embryo and later throughout the developing axis. It too 
lacks a secretory signal sequence, but may still be secreted. 
With eFGF, the localization also appears to be in the animal hemisphere of the 
blastula stage embryo however this FGF does indeed possess a signal sequence. Despite 
this fact, none of the four FGF s found in X laevis appear to be at the right place at the 
right time to be one of the vegetally localized mesoderm inducing signals. That is, none 
of them are vegetally localized. Yet, they still appear to be required for mesoderm 
formation, as demonstrated by the work of Amaya and his colleagues (Amaya et al., 
1991; Amaya eta/., 1993). A new role therefore has emerged for FGFs. Rather than 
acting as the signals themselves, they appear to be present in the animal hemisphere as 
competence factors for the cells in the marginal zone receiving the mesoderm induction 
signal (Isaacs, 1997). Their activity in the region then continues in the maintenance of 
this tissue after induction is complete. 
Supporting this theory is the finding that eFGF expression is activated in animal 
caps treated with mesoderm inducing factors (Isaacs eta/., 1994). It is therefore likely 
that the same occurs in the presumptive mesoderm of the developing embryo. But levels 
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of eFGF are highest in the mesoderm during gastrulation (Isaacs et al., 1994) after this 
tissue has already been induced, reinforcing the role ofFGFs in mesodermal tissue 
maintenance. Nevertheless, the role ofFGFs during mesoderm induction is still integral 
to the development of a normal embryo. In fact, the establishment and preservation of 
mesoderm in X /aevis has been shown to depend upon FGF signalling within this tissue 
by way of a regulatory loop involving Xbra (Isaacs eta/., 1994). The FGF pathway must 
be intact downstream of Xbra to allow it to in turn activate the expression of eFGF which 
then regulatesXbra expression (Schulte-Merker & Smith, 1995). 
1.6 FGF signal transduction 
FGF signal transduction begins at the cell surface with a ligand and a 
transmembrane receptor. In the FGF signal transduction pathway, the receptor is a high 
affinity receptor that is a member of the tyrosine kinase receptor family. There are four 
known FGF receptor genes, named FGFR-1 through FGFR-4, that share 55% to 72% 
sequence homology at the protein level (reviewed in Powers eta/., 2000). These 
receptors are transmembrane proteins possessing three extracellular immunoglobulin 
(Ig)-like domains (lgl, Igii, and lgiii), an acidic region situated between Igi and II, a 
transmembrane domain, and an intracellular tyrosine kinase domain (Figure 1.4). 
Diversity of the four FGFRs can be enhanced through the expression of splice variants of 
the FGFR genes. This enables the same FGFR gene to code for a number of different 
receptor protein isoforms. It is thought that the expression of different isoforms allows 
for the great diversity seen in FGF function. 
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Figure 1.4 Schematic of the FGF receptor 
FGF receptors are transmembrane proteins possessing three extracellular 
immunoglobulin (Ig)-like domains (designated Igl, lgll, and Iglll above), an acidic 
region situated between lgl and II, a transmembrane domain, and intracellular tyrosine 
kinase domains responsible for phosphate transfers to the tyrosine residues of other 
proteins. Adapted from Powers eta/. (2000). 
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FGF receptors are similar to other receptor tyrosine kinases in that they transmit 
extracellular signals through the cell membrane to various signal transduction pathways 
in the cytoplasm by tyrosine phosphorylation. FGF ligands are thought to first bind to 
low affinity receptors in the extracellular matrix (ECM). This promotes binding of the 
ligand to the high affinity tyrosine kinase receptors (RTK) (Powers et al., 2000). Once a 
ligand binds to one of these receptors, the receptor dimerizes giving it the ability to 
phosphorylate specific tyrosine residues on its own as well as on its partner's cytoplasmic 
tail. This dimerization and phosphorylation can occur between both homodimers as well 
as heterodimers of different FGFRs and enhances the diversity ofFGF signalling (Powers 
et al., 2000). After a receptor has been activated in this manner, it can recruit additional 
signalling molecules to propagate the signal through many possible pathways. 
Within X laevis, three FGFR members have been identified: FGFR1, -2, and -4. 
Of these, the FGFR1 appears to be important in early development, as it has been shown 
to be present in the embryo at this time (Musci & Kirschner, 1990). Localization of its 
mRNA and protein is predominantly in the animal hemisphere, which is similar to the 
FGF protein ligands. As well, this receptor is activated during mesoderm induction in X 
laevis (Ryan & Gillespie, 1994 ). 
Triggering ofthe FGFR in X laevis by FGF binding leads to the recruitment of 
signalling molecules, including several SH2-containing proteins that play specific roles 
within the FGF signalling pathway (Mohammadi et al., 1991; Ryan & Gillespie, 1994; 
Zhan et al., 1994; Larsson et al., 1999). These target proteins interact with the 
cytoplasmic tail of the receptor, which in turn modifies them by phosphorylation. They 
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can then act as substrates for receptor-mediated phosphorylation or may function as 
adaptor proteins to recruit other targets (Powers et al., 2000). While not all of these 
molecules affect the induction of mesoderm in animal cap explants, there appears to be 
two active FGF pathways triggered in this manner that are required for mesoderm 
development: the ras/raj!MAPK pathway and the phosphoinositide 3 kinase (PI3K) 
pathway. A third pathway, the PLCy pathway, may also be involved in this process. 
MAP kinase, or Mitogen Activated Protein kinase, is a serine-threonine kinase 
that is activated in response to a variety of stimuli (Hartley et al., 1994). The kinase that 
is responsible for the activation is known as MEK, or MAP kinase kinase (MAPKK), 
which itself gets phosphorylated by MEK kinases (MEKK). One type ofMEKK is RAF, 
which is activated in a complex together with RAS. Both are proto-oncogenes known to 
lie downstream of tyrosine kinase receptors. When the FGF receptor is activated, it gets 
bound by docking molecules such as FRS2. These recruit a protein complex known as 
GRB2-SOS. SOS then causes the dissociation ofGDP from the membrane-bound RAS, 
enabling it to associate with G TP and become activated. RAS can then recruit RAF -1, 
which can in turn activate MAPKK. This latter molecule activates MAPK, enabling it to 
phosphorylate transcription factors and other substrates. 
With respect to the second pathway, PI3Ks are lipid kinases that phosphorylate 
the 3 '-OH position of the inositol ring to give rise to a variety of activated membrane 
phospholipids. These phospholipids have the ability to act as second messengers and are 
known to regulate numerous processes within the organism. Similar to the MAPK 
signalling cascade described above, the PI3K pathway was recently shown to be turned 
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on by RAS as well (Carballada eta/., 2001). It was also demonstrated that these signals 
act in parallel to the MAPK pathway and are required for the formation of trunk 
mesoderm in X laevis during blastula stages. 
. 
In the phospholipase C gamma (PLCy) pathway, PLCy gets activated resulting in 
the hydrolysis ofphosphatidylinositol4,5-biphosphate to both diacylglycerol and IPJ. 
The former activates protein kinase C (PKC) while the latter causes the release of Ca2+ 
from intracellular stores. Both of these second messengers activate other molecules that 
ultimately bring about the transcription of target genes. While this pathway is activated 
during FGF-induced mesoderm induction in animal cap explants, it is not sufficient to 
induce mesoderm in explants, although it may be part of a negative feedback mechanism 
on FGF signalling (Gillespie et al., 1992). 
The greatest evidence for the role of FGF signalling in mesoderm formation . 
comes from investigating the consequences of its inhibition. One of the most visible 
effects seen with these experiments is on the expression of mesodermal markers at the 
beginning of gastrulation (Isaacs, 1997). The inhibition ofFGF signalling causes a 
decrease in the levels of Xcad3 (Xenopus caudal) and Xbra, which are normally 
expressed in the entire marginal zone at this point in development (Amaya et al., 1993; 
Northrop & Kimelman, 1994). Noggin expression is also down regulated but not as 
much as the first two. XmyoD does not appear to be affected initially but is greatly 
reduced at the end of gastrulation and the beginning of the neurula stages (Fisher eta/., 
2002). Also, the expression of Xgsc, Xwnt-8, and Xsna (Xenopus snail) in the prospective 
mesoderm at the start of gastrulation is not affected by FGF inhibition (Amaya eta/., 
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1993; Christian & Moon, 1993). Thus, the proper functioning of the FGF signalling 
pathway is required in the early embryo in order to promote or maintain the expression of 
some but not all of the genes throughout the developing mesoderm (Isaacs, 1997). 
1. 7 Immediate-early genes 
In a signal transduction cascade such as that induced by FGF, the pathway 
transmits a signal from the extracellular environment to the nucleus resulting in the rapid 
transcription of specific genes in the cell. These first genes to become transcribed in 
response to a signalling pathway are known as immediate-early or early-response genes. 
Immediate-early genes are frequently transcription factors, and for this reason they are 
often targeted to the nucleus. Their expression can therefore lead to the transcription of 
even more genes that ultimately carry out the requirements or functions relayed by the 
original signal. Immediate-early genes are identified by their ability to be transcribed in a 
manner independent of de novo protein synthesis, along with the rapidity of their 
expression, thus reinforcing their role as the very frrst genes to be transcribed in a 
signalling pathway. 
1.8 MI-ERl 
In an effort to further elucidate the FGF signal transduction pathway, an attempt 
was made in the Terry Fox Cancer Research Lab to identify the particular immediate-
early genes that are active in this signalling cascade. Resulting from this search was the 
discovery of a novel, developmentally regulated gene encoding a nuclear protein that was 
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activated by FGF-2 in X laevis (Paterno eta!., 1997). This gene was eventually named 
mesoderm induction ~arly response l, or mi-er 1. Xmi-er 1, the X laevis form, was 
isolated using polymerase chain reaction-based differential display (Paterno et al., 1997) 
and demonstrated increased expression levels in animal cap explants in response to 
treatment by FGF-2. The PCR product that was obtained through this method was then 
cloned and found to represent a 2.3-kilobase pair eDNA encoding a protein of 493 amino 
acids (aa). By analyzing its expression in FGF-2-treated animal caps in the presence of 
cycloheximide, a protein synthesis inhibitor, it was found that transcription of Xmi-er1 
was not dependent upon de novo protein synthesis. This suggested that Xmi-er 1 was a 
true immediate-early gene. Further support for this concept came from the fact that the 
gene was targeted exclusively to the nucleus during immunocytochemical analysis, and 
an acidic domain at the N terminus was found to function as a potent transcriptional 
activator when tested in mammalian cells (Paterno eta!., 1997). Thus, all of the evidence 
supported a role for Xmi-er 1 as an early-response gene within the FGF signalling 
cascade, suggesting that this molecule played a part in FGF-regulated cellular activities. 
Subsequent studies on this gene led to the discovery of a closely related human 
homologue, hmi-er1 (Paterno eta/., 1998). The two proteins showed 91% sequence 
similarity. Analysis of hmi-er1 expression in numerous human tissues revealed that 
mRNA levels were negligible in aliSO normal human tissues tested. However, upon 
examination of various breast carcinoma-derived cell lines and breast tumour tissue 
samples, it was indicated that hmi-er 1 was expressed at significant levels in all samples 
but remained undetectable in normal breast-derived cell lines and tissue. Two of the 
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major isoforms, hMI-ERla. and hMI-ERlf3, were recently found to function as 
transcriptional repressors by the recruitment of histone deacetylase I (HDACI) through 
the highly conserved ELM2 domain (Ding et al., 2003). 
Within both XMI-ER1 and hMI-ERI, there appears to be a number of conserved 
functional domains, the ELM2 being one of them, to be discussed in full detail below 
(Figure 1.5). At theN-terminus there are four highly conserved acidic regions. Towards 
the centre of the molecule is the aforementioned ELM2 domain (aa 168-272) and along 
the C-terminal side of this is a second large domain known as the SANT domain (aa 276-
321). This is followed by a putative MEK phosphorylation site (TDY), a proiine-rich 
(PXXP) motif, as well as the only functional nuclear localization signal (NLS) (Post et 
al., 2001). Between XMI-ERl and hMI-ERl, there is 100% identity within the SANT 
domain, the NLS, and the proline-rich region. 
During X laevis embryonic development, the XMI-ERl protein is present in the 
early embryo (Paterno et al., 1997). It is a maternally derived protein that is found at 
constant levels during early developmental stages and only becomes localized in the 
nucleus at MBT (Luchman et al., 1999). Using an anti-MI-ERl antibody on whole 
mounts and sections, this movement into the nucleus can be frrst seen in the cells of the 
future mesoderm at stage 8. Following this, XMI-ER1 becomes localized to the nucleus 
in the cells of the presumptive ectoderm, and by late blastula all of the nuclei in the 
animal hemisphere are stained. Nuclear localization occurs last in the endodermal cells. 
At early gastrula stages, the nuclear localization ofXMI-ER1 is ubiquitous in the 
embryo. At later stages following this, the protein gradually disappears from the nuclei 
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such that by tadpole stages it is gone from all nuclei with the exception of a few cells in 
the endoderm. Some mesodermal tissues at this point also show cytoplasmic staining. 
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Acidic Domains 
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Figure 1.5 Illustration of the putative functional domains in XMI-ERl 
The N-terminal domain consists of four regions of acidic amino acids. Located in the 
centre of the protein is the ELM2 domain. Towards the C-terminus, the SANT domain 
can be found, followed by a putative MEK phosphorylation site (TDY), a PXXP motif, 
and a bonafide NLS. 
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1.8.1 The ELM2 domain 
The ELM2 domain, which stands for E.GL.-27 and MTA1 homology domain 2, 
was initially identified in EGL-27 (Solari et al., 1999). EGL-27 is a C. elegans protein 
that is involved in embryonic patterning and plays a key role in Wnt signalling possibly 
by regulating HOX gene expression (Herman eta/., 1999; Solari eta/., 1999). It is 
thought to act in the regulation of transcription factors that function during embryonic 
patterning by way of a protein complex that may alter the acetylation status of the target 
chromatin. Recent data suggests that the transcriptional activity of a gene can be 
controlled by modifications of its chromatin structure (Wade eta/., 1999; Sterner & 
Berger, 2000). That is, when the chromatin is acetylated, the gene is active, and when the 
chromatin has been deacetylated, the gene is inactive or repressed. The second gene for 
which the ELM2 domain is named is mta1. This encodes a protein that is known to be 
part of a protein complex possessing ATP-dependent nucleosome remodelling and 
histone deacetylating activities (Xue eta/., 1998). Thus, it is thought to be involved in 
gene repression by hypoacetylating chromatin. The ELM2 do~ain is a highly conserved 
sequence that is also found in many SANT domain-containing proteins. It has recently 
been shown to recruit HDAC1 and to be required for transcriptional repression (Ding et 
a/.,2003). 
1.8.2 The SANT domain 
The SANT domain was named for the four transcription factors in which it was 
first discovered: SWI3, ADA2, N-CoR, and IFIIIB (Aasland et al., 1996). The motif 
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consists of approximately 50 amino acid residues and is often found more than once 
within a protein. In general, there tend to be a number of highly conserved residues 
throughout the domain including two or three regularly spaced aromatic amino acids 
. 
thought to be important in the maintenance of its hydrophobic core. Within the XMI-
ER1 SANT domain, there are two tryptophans at amino acids 6 and 48, and a 
phenylalanine at amino acid number 25. 
Although the function of the SANT domain has yet to be fully understood, it is 
thought to act in transcriptional regulation either through DNA binding or protein-protein 
interactions (Aasland et al., 1996). In fact, it is highly related to the DNA-binding 
domains of myb-related proteins and may therefore function in a similar manner. Like 
these domains, the SANT domain has two or three repeated subdomains each resembling 
the helix-loop-helix design in secondary structure. These are thought to assist with DNA 
binding. However, studies suggest that only those proteins that have ,two or more SANT 
domains are involved in DNA binding (Aasland et al., 1996). Proteins with only one 
SANT domain are more likely to function in protein-protein interactions. Recent data has 
demonstrated that CoREST, a corepressor to the REST transcription factor, interacts with 
HDAC through its single SANT domain (You et al., 2001 ). It is therefore probable that 
XMI-ER1, which has only one SANT domain, is involved in transcriptional regulation 
via protein-protein interactions rather than DNA binding. 
1.8.3 The proline-rich region 
At the C terminus ofXMI-ER1 there is a proline-rich motif that conforms to the 
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consensus PXXP for binding Src homology 3 (SH3)-containing proteins (Ren et al., 
1993; Cohen et al., 1995). SH3 is a small domain that is present in many proteins, 
especially those involved in signalling. These domains are thought to operate as modules 
that mediate protein-protein interactions and control signalling within the cell (Cohen et 
a/., 1995). Binding domains that are designated as being "modular" are often constructed 
with two related features: a common core able. to recognize other proteins; and, a second 
more specific means of control. Using this system of both general and precise regulation, 
these modulators are able to arbitrate the interaction of one protein with another and in 
this way they aid and perhaps direct many signal transduction pathways. The presence of 
a region concentrated in prolines that can potentially interact with SH3-containing 
signalling molecules therefore supports the idea ofXMI-ER1 functioning in 
transcriptional regulation via protein-protein interactions. 
1.9 Project Goals 
The purpose of this study was twofold: ( 1) to investigate the function of XMI-
ERI during X laevis development and mesoderm induction; and, (2) to identify 
functional domains that are integral to XMI-ERI activity during development. 
Part 1) Investigation of XMI-ERl function during X laevis development and 
mesoderm induction. 
At the time this project was undertaken, not much was known about the activity 
ofXMI-ERl in development. It was found to be present in the early embryo, and its 
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expression pattern had recently been elucidated (Luchman et al., 1999), but little was 
known about its role during this time. In an attempt to contribute to the general 
understanding ofXMI-ERl, I began my research with a series of in depth over-
expression experiments in the early X laevis embryo. Following these studies, its role 
was further analyzed during FGF- and activin-induced mesoderm induction in animal 
caps. This was achieved by culturing stage 8 animal caps in a series of concentrations of 
these two potent mesoderm inducers. 
Part 2) Analysis of functional domains critical to XMI-ERl activity. 
This was accomplished through an examination of the domains present in the full-
length protein. The analytical techniques used involved the mutagenesis of potentially 
key amino acids within these domains. Residues were deemed to be "key" based on 
comparisons with other proteins containing the same domains. The activity of these 
mutated forms ofXMI-ERl was then investigated within both the developing embryo 
and animal caps and compared to the activity of the wild-type XMI-ERl form. 
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Chapter 2: Materials and Methods 
2.1 In vitro fertilization of X laevis eggs 
Adult female X laevis frogs (Nasco) were injected subcutaneously in the upper 
hind leg on the dorsal side with 550 I.U. of Human Chorionic Gonadotrophin (Sigma) 14 
to 16 hours before embryos were needed. The frogs were then left at room temperature 
overnight to ovulate. The following morning, eggs were collected from the induced 
females in a petri dish (Fisher) by gentle massaging. The eggs were fertilized with a 
small piece of testes obtained from a previously sacrificed adult male frog. Whole testes 
were stored in IX Normal Amphibian Medium (NAM; Table 2.1) (Slack & Forman, 
1980) at 4°C and had a shelf life of approximately a week and a half. A small portion of 
the testes was macerated and diluted with 2-3ml of distilled water ( dH20) and then added 
to the isolated eggs. In order to mix the eggs and sperm together, the petri dish was 
rocked for a few seconds and then left at room temperature to allow the fertilization to 
take place. After ten minutes, the eggs were flooded with enough dH20 so that they were 
completely submerged. A waiting period of 5-15 minutes was then required to let the 
eggs rotate so that the animal pole was facing up, indicating a successful fertilization. 
Once this cortical rotation occurred, the embryos were de-jellied in order to 
facilitate manipulation during injections. In this step, the embryos were swirled in 50ml 
of 2% L-cysteine (Sigma) in dH20, pH 7.8-8.1, until all the jelly had dissolved and the 
embryos were packed closely together. They were then rinsed with IL of dH20 and 
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transferred to a petri dish containing NAM/20 where they were left to develop at room 
temperature until required. 
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Table 2.1 Components of Normal Amphibian Medium (NAM) used for X 
laevis experiments 
Composition and concentration of lOX stock and lX solution 
lOX stock lX solution 
(giL) (mM) 
NaCl (Fisher) 65 110 
KCI (Fisher) 1.5 2 
Ca(N03)2 •4H20 (Fisher) 2.4 1 
MgS04 •7H20 (Fisher) 2.5 1 
EDTA (O.SM, pH 8) (Fisher) 2ml 0.1 
Hepes (1M, pH 7.5) (Fisher) 100ml 10 
Composition ofNAM Solutions (in 100 ml) 
lXNAM NAM/2 NAM/20 
(ml) (ml) (ml) 
lOXNAM 10 5 0.5 
Gentamycin (Sigma) 0.25 0.25 0.25 
NaHC03 (Fisher) 1.0 1.0 0 
dH20 88.75 93.75 99.25 
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2.2 Microinjection of X laevis embryos 
When the embryos had reached the two-cell stage approximately 1.5 hours after 
fertilization, the required number of embryos (usually 30-50) was transferred to a grid-
lined petri dish containing NAM/2 + 4% ficoll (Amersham). A glass needle made from 
a 31 h" Drummond glass capillary tube that had been pulled using a Narishige PB-7 
micropipette puller and ground using a Narishige EG-40 grinder was then filled with 1 J.ll 
DEPC- (Sigma) treated dH20. Each embryo was injected with 4.6nl ofliquid in the 
marginal zone beside the cleavage furrow. Once the injections were complete, the group 
was transferred to another petri dish also filled with NAM/2 + 4% ficoll and left to 
develop at room temperature. This procedure was repeated for each RNA concentration 
injected. Injected embryos were scored for phenotypic abnormalities using the Normal 
Table of Xenopus laevis (Nieuwkoop, 1994) 24 and 72 hours post-injection. The dorsa-
anterior index (DAI)(Kao & Elinson, 1988) was also utilized at the latter stage. Once 
these scores were collected, the embryos were fixed in a solution ofMEMFA (Table 2.2) 
and stored in glass scintillation vials (Fisher) at 4°C for further study. The MEMF A was 
eventually replaced with IX PBSA + 0.02% azide (Fisher; Table 2.3). 
Injections for the FGF- and activin-induced mesoderm induction experiments 
were carried out at the four-cell stage. These embryos were injected in the animal pole of 
each cell with 2.3nl of liquid so that a total of9.2nl was injected per embryo. 
Approximately 40 embryos were injected for each set with 0.375ng/2.3nl dilutions of 
RNA The total RNA injected into each embryo under these conditions was therefore 
1.5ng. They were then left at room temperature until stage 8 at which point they were 
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used for mesoderm induction assays (see 'Micro-dissection and Induction Assays'). The 
purpose of injecting them in the animal cap of four cells rather than into one or two cells 
at an earlier stage was to ensure that when the explants were excised, the cut included the 
part of the animal cap that had been injected. 
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Table 2.2 Components ofMEMFA 
For 1L Solution Final Concentration 
(mL) (mM) 
MOPS (1M, pH 7.4) (Fisher) 100 100 
EGTA (0.5M, pH 8.0) (Fisher) 4 2 
MgS04 (1M) (Fisher) 1 1 
Formaldehyde (37%) (Fisher) 100 3.7% 
dH20 795 N/A 
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Table 2.3 Components of lOX Phosphate Buffered Saline Amphibian (PBSA) 
For lL Solution Final Concentration 
(giL) (mM) 
NaCl (Fisher) 56.0 100 
KCl (Fisher) 1.4 2 
KH2P04 (Fisher) 1.7 5 
NazHP04•7HzO (Fisher) 15.1 1.5 
dHzO Up to 1L; pH 7.4 N/A 
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2.3 Micro-dissection and induction assays 
Approximately 4.5 hours after fertilization when the embryos had reached stage 
7.5, a solution ofNAM/2 + lmg/ml Bovine Serum Albumin (BSA, RIA grade; Sigma) 
was prepared fresh. This was used to make a set of serial dilutions of the FGF or activin 
to be used for culturing animal caps. The FGF used in this study was recombinant 
Xenopus FGF-2. It was expressed and purified according to Kimmelman et al. (1988). 
The stock concentration was 18.5J.Lg/ml and was stored in aliquots at -20°C. 
At stage 8 the embryos were transferred to a petri dish lined on the bottom with 
1.5% agar (Fisher) in NAM/2 and filled with IX NAM solution. Animal cap explants 
were dissected manually according to Godsave et al. (1988). The vitelline membranes 
were removed using forceps and the top 1/4 of each embryo was cut in a square shape 
also with forceps and removed from the animal cap. The explants were transferred to a 
multi-well plate and cultured in 20J.Ll ofliquid, whose constitution and concentration 
varied according to the experiment being performed, as described below. 
There were three different induction experiments that were conducted in this 
project. For the FGF-induced mesoderm induction ofXmi-erl- or water-injected 
embryos, four culturing conditions were prepared. NAM/2 + lmg/ml BSA was used as a 
negative control for induction in addition to four concentrations ofFGF-2: 0.5ng/ml, 
l.Ong/ml, 2.0ng/ml and 5.0ng/ml. Five explants from each injection set were cultured in 
the control condition, while ten from each set were cultured in each dilution of FGF. 
Thus, a total of 45 explants were cut from each set of injected embryos and a total of 90 
explants were cut and cultured per experiment. 
42 
For the FGF-induced mesoderm induction of the XMI-ERI constructs, explants 
were cut from embryos injected with a total of l.Sng of Xmi-er 1, 365PS~AA, 365P~A, or 
366S~A, or with DEPC-treated dH20. They were cultured in 20J.Ll of lng/ml FGF, or in 
NAM/2 + lmg/ml BSA as a negative control. Again, five explants from each injection 
set were cultured in the control condition, while ten from each set were cultured in FGF. 
In the activin induction experiment, explants were cut from embryos injected with 
a total of l.Sng of Xmi-erl or with DEPC-treated dHzO. They were cultured in one of 
five concentrations of recombinant human activin (rhActivin; R&D Systems) that 
included O.Olng/ml, 0.025ng/ml, 0.05ng/ml, O.lng/ml, and 0.15ng/ml, orNAM/2 + BSA 
as a negative control. For this experiment, five explants per injection set were cultured in 
each condition such that a total of 30 explants were cut from each set and 60 were cut for 
the whole experiment. 
Approximately 24 hours after fertilization, 7J.tl of dHzO was added to each well in 
order to accommodate for evaporation of liquid and to increase survival. Explants were 
left in the multi-well trays for 3 days and scored for mesoderm formation on the third day 
following injection (after 72 hours). Mesoderm induction by FGF and activin were 
scored as first described by Slack eta/. (1987); i.e., an explant was positive for induction 
if it both elongated from its initial ball-like shape and expanded to resemble a bubble. 
Once these scores were recorded, the explants were fixed in MEMF A and stored in 1 X 
PBSA + 0.02% azide at 4°C for further investigation. 
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2.4 Mutagenesis 
In order to create the desired mutations in the Xmi-erl DNA sequence two 
different methods were employed. For iJ.175"236EIM2, two endogenous BamH1 sites were 
used to delete the specified sequence from wild-type xmi-erl. With respect to the 
remaining constructs, the QuikChange™ Site-Directed Mutagenesis Kit (Stratagene) was 
utilized. This is an in vitro mutagenesis technique that is able to introduce mutations into 
any double-stranded plasmid using the polymerase chain reaction (PCR). The reaction 
was made up of the provided lOX reaction buffer, dNTP mix, and PfuTurbo™ DNA 
polymerase; the two primers containing the desired mutation (one primer for each strand 
of DNA; Table 2.4); dH20; and the plasmid DNA The cycling parameters were as 
described in the PCR section. 
Once the PCR was finished, the products were run on a 1% agarose gel to check 
for sufficient amplification. The samples were then digested with the provided Dpn 1 
restriction enzyme. 1 J .tl was added to each reaction and mixed gently by pipetting up and 
down several times. This was incubated at 37°C for 1 hour in order to digest the parental 
strand and to ensure that only the mutated DNA remained. The endonuclease used in this 
step is specific for methylated and hemi-inethylated DNA only and is therefore able to 
target the non-mutated parental DNA template. Following the digestion, the products 
were transformed into the provided Epicurian coli® XLI-Blue Supercompetent Cells. lJ.I.l 
· of product was combined with 50J.I.l of cells and incubated on ice for 30 minutes. The 
cells were then heat-shocked at 42°C for 45 seconds and placed on ice again for 2 
minutes. A mixture of preheated NZY+ broth (Table 2.5) was added to this. The sample 
44 
was shaken at 37°C for 1 hour at 225 rpm. The entire reaction was then plated on a 
50J..Lg/ml ampicillin (Sigma)+ LB agar plate (Table 2.6) and grown overnight at 37°C. 
The resulting colonies were subsequently used for plasmid preparations and RNA 
production. 
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Table 2.4 List of primers used to make mutations 
Mutation Primers 
277W~A 5'CTTCTTCAGTCGCAACGGAAAGTTCTTCTCTGGCGG3' 
. 
5'CCGCCAGAGAAGAACTTTCCGTTGCGACTGAAGAAG3' 
2nW-+G 5'GCCAGAGAAGAACTTTCCGTTGGGACTGAAGAAGAA TGTAGJ' 
5'CTACATTCTTCTTCAGTCCCAACGGAAAGTTCTTCTCTGGC3' 
d 92YGKDF 5'GAGCAAGGTCT AAAAGCTCACTTGATTCAGGCJ' 
5'GCCTGAATCAAGTGAGCTTTTAGACCTTGCTC3' 
319W~A 5'GTGTGGCATTCTACTACATGGCGAAAAAA TCAGAACGTTATGACJ' 
5'GTCAT AACGTTCTGATTTTTTCGCCATGTAGTAGAATGCCACACJ' 
346TDY~ADF 5'CTACATCCTGGTGTAGCGGATTTCATGGATCGTCTTTTGG3' 
5'CCAAAAGACGATCCAGGAAATCCGCTACACCAGGATGTAG3' 
36sps~AA 5'CCTCCAGCAGGGCGGCAGCTCCTCCACCAACTACCTCC3' 
5;GGAGGTAGTTGGTGGAGGAGCTGCCGCCCTGCTGGAGG3' 
36sP~A 5'CCAGCAGGGCGGCATCTCCTCCACCAACTACCTCC3' 
5'GGAGGTAGTTGGTGGAGGAGATGCCGCCCTGCTGG3' 
366S~A 5'CCAGCAGGGCGCCAGCTCCTCCACCAACTACCTCC3' 
5'GGAGGTAGTTGGTGGAGGAGCTGGCGCCCTGCTGG3' 
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Table 2.5 Components ofNZY+ broth 
giL 
NZ amine (or casein hydrolysate) (Difco) 10 
yeast extract (BDH) 5 
NaCl (Fisher) 5 
dH20 up tolL; pH 7.5 
Prior to use add: 
MgCh (Fisher) 12.5ml 
MgS04 (Fisher) 12.5ml 
2M glucose (Sigma) lOml 
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Table 2.6 Composition of Luria-Bertani (LB) Medium agar plates 
giL 
peptone (BDH) 10 
yeast powder (BDH) 5 
NaCl (Fisher) 10 
agar(BDH) 15 
dH20 up to 1L; pH 7.0 
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2.5 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) was used to amplify DNA sequences during 
the formation of the XMI-ER1 constructs. This in vitro technique uses two 
oligonucleotide primers that hybridize to opposite strands of DNA to carry out the 
synthesis of a specific DNA sequence with the help of an added enzyme (Erlich, 1989). 
The three steps to this reaction are denaturation of the template strand, annealing of the 
primers, and extension of the DNA sequence from the primers. When put together, these 
steps make up one cycle in the reaction. It is the repetition of these cycles that allows for 
the exponential accumulation of the target sequence. 
The general PCR protocol used was as follows. Prior to each reaction, a master 
mix was prepared by combining the enzyme buffer (Promega) with dNTPs (Gibco), 
MgClz (Promega), and deionized water. The Taq DNA Polymerase was added next, 
followed finally by the appropriate primers (Table 2.4). The reaction was carried out in a 
. 
thermal cycler using three steps. The cycling parameters used for making 292 !J. YGKDF 
and 277W ~G involved the following program: 
1 cycle: 95°C for 30 seconds 
X cycles: 95°C, 30 seconds for denaturation 
55°C, 1 minute for primer annealing 
68°C, 9 minutes and 36 second for primer extension 
X represented 18 cycles for the former construct and 12 cycles for the latter. 
For the !J.ELM2 deletion, a slightly different program was used: 
1 cycle: 94 °C, 5 minutes 
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35 cycles: 94°C, 55 seconds for denaturation 
55°C, I minute for primer annealing 
72°C, I minute for primer extension 
I cycle: 72°C, 6 minutes 
Once completed, the PCR products were examined on a I% agarose gel. 
2.6 Agarose gel electrophoresis 
This technique was used in order to separate nucleic acids according to size by 
taking advantage of the fact that these molecules ar~ highly charged. All gels were made 
up of I% agarose ( Gibco) in I X tris borate I EDT A electrophoresis buffer (TBE; Table 
2.7) and were stained with ethidium bromide (Bio-Rad). This binds to the nucleic acids 
and enables them to be visualized under ultraviolet light. 
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Table 2.7 Components of TBE 
lOX stock lX solution 
Tris base (Fisher) 108g 10.8g 
Boric Acid (Fisher) 55g 5.5g 
EDTA (0.5M, pH 8.0) (Fisher) 40ml 4ml 
dH20 up tolL up tolL 
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2. 7 Plasmid preparation and purification 
Two different methods were used for the preparation ofplasmids. The XMI-ERl 
constructs were made by the first method of transformation, inoculation, and isolation 
using a plasmid preparation kit (Qiagen), while XMI-ERl itself was prepared using the 
cesium chloride method because attempts to use the first method with this sequence were 
unsuccessful. 
Method 1: 
In order to amplify plasmid DNA, it was transformed into Epicurian coli® XLI-
Blue Supercompetent Cells (Stratagene) and cultured overnight. The transformation 
reaction involved adding approximately lOng of DNA to the cells. This was gently 
swirled and incubated on ice for 30 minutes. The cells were then heat-shocked at 42°C 
for 45 seconds and placed on ice for 2 minutes. A mixture of preheated NZY + broth 
(Table 2.5) was added to this and the sample was shaken at 37°C for I hour at 225 rpm. 
The entire reaction was then plated on an LB + ampicillin agar plate and grown overnight 
at 37°C. 
The next morning, the plates were checked for bacterial colony growth. If growth 
was successful, the plates were wrapped in parafilm (American National Can) and stored 
at 4°C. If not, the previous step was repeated until growth was observed. Once this 
occurred, two colonies were chosen from each plate and used for an inoculation. This 
technique enables the growth of individual bacterial colonies from which plasmid DNA 
will be isolated. The colonies were grown in large flasks of LB medium and ampicillin. 
These were incubated overnight at 37°C with vigorous shaking (~225 rpm). 
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To isolate plasmid DNA from the cultured bacterial cells, the HiSpeed Plasmid 
Midi Kit (Qiagen) was used. The protocol was carried out as per the manufacturer's 
directions. The plasmid DNA was checked by agarose gel electrophoresis and stored at 
4°C. 
Method2: 
This method involved a number of steps carried out over three consecutive days. 
On the ftrst day, a previously preparedXmi-erl glycerol stock was grown in LB + 
ampicillin overnight at 37°C while shaking at ~230rpm. The following day, 1.5ml of 
culture was combined with 300J.1l glycerol and stored as a stock at -80°C. The remaining 
culture was transferred to 250ml bottles, cooled on ice for 20 minutes, and then 
centrifuged at 4000rpm for 5 minutes. The supernatant was drained off and the pellet 
was re-suspended in 6.5ml of solution #1 (see Table 2.8 for composition of solutions). 
This was transferred to a 50ml Oakridge tube and left at room temperature for 5 minutes. 
13ml of solution #2 was then added to lyse the cells and the sample was placed on ice for 
5 minutes. 6.5ml of solution #3 (pre-chilled on ice) was added next in order to precipitate 
the chromosomal DNA and protein, and placed on ice for 10 minutes. The sample was 
then centrifuged at 12000rpm for 30 minutes. The resulting supernatant was carefully 
poured into a fresh Oakridge tube and precipitated with 2-propanol (Fisher). This was 
left at room temperature for 15 minutes, and the sample was once again centrifuged at 
8000rpm for 30 minutes. Following this, the supernatant was drained and discarded, and 
the pellet was re-suspended in 3ml of solution #4. The sample was then topped off with 
this solution so that the total volume was 4.2ml. This was transferred to a 15ml Corex 
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tube. 42!-ll ofRNase A (Boehringer Mannheim) was then added followed by 4.7g of 
CsCl. The tube was placed at 37°C to dissolve fully. 0.5ml of 10mg/ml ethidium 
bromide was added next and the sample was centrifuged at 8000rpm for 10 minutes. The 
clear supernatant was injected into a quick seal tube using a syringe. The tube was then 
balanced, heat-sealed, and centrifuged at 45000rpm overnight at 20°C. 
The next day, the tube was removed carefully from the rotor, and the plasmid 
DNA was taken out under UV light using a 16-gauge needl~. The ethidium bromide was 
extracted using an equal volume of water-saturated butanol (BDH). This was repeated 
six times, followed by two extractions with phenol: chloroform: isoamylalcohol25:24:1 
(P:C:I~ Invitrogen) and one chloroform extraction. The DNA was then precipitated with 
1/10 the volume of 3M sodium acetate, pH 5.2, and 2 times the volume of 100% ethanol 
(Fisher) and incubated at -20°C for 1 hour. The precipitate was centrifuged at 8000rpm 
for 30 minutes. Next, the supernatant was drained off and the pellet was washed with 
70% ethanol and dried under vacuum. It was then re-suspended in solution #4 and tested 
on a 1% agarose gel. RNA contamination was removed using 201J.l RNase A (lOmg/ml) 
and incubating at 37°C for 20 minutes. The sample was once again extracted using P:C:I, 
sodium acetate, and ethanol, and the final product was stored at 4°C. 
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Table 2.8 Components of the four plasmid preparation solutions 
Solution Components Final Concentration 
1 Glucose 50mM 
1M Tris, pH 8.0 25mM 
0.5MEDTA lOmM 
2 10%SDS 
lONNaOH 2mM 
3 5MCH3COOK 3M 
Glacial Acetic Acid 11.5% 
4 Tris, pH 8.0 50mM 
EDTA,pH8.0 lmM 
55 
2.8 Sequencing plasmid DNA 
This procedure was used in order to confirm the nucleotide sequences of all RNA 
constructs used for injections. It was carried out using the USB Sequencing Kit. The 
method involved three major steps: denaturing, annealing, and labelling. In the frrst step, 
a solution of0.2N NaOH (Fisher) and 0.2M EDTA was added to 5J.1g of plasmid DNA. 
This was incubated at 37°C for 20 minutes. Next, it was precipitated using 3M sodium 
acetate, pH 5.2, and 95% ethanol. The sample was then mixed, briefly.centrifuged, and 
placed at -70°C for 15 minutes. Following this was a 20-minute centrifugation at 4°C. 
The resulting DNA pellet was washed using 70% ethanol, spun again, dried, and re-
suspended in 7 J.ll of dH20 .. 
In the annealing step, the provided sequencing reaction buffer was added to the 
DNA, along with 1 Ong of primer. This was mixed and heated at 65°C for 2 minutes. 
Following this was a slow cool down, which took approximately 20 to 30 minutes. Once 
cool, the samples could be placed on ice. 
In the final step, the annealed primer-DNA was combined with O.lM 
dithiothreitol (DTT), diluted labelling mix, [a35S]·dATP (NEN Technologies), and the 
sequenase enzyme. Mter 5 minutes, 3.5).11 of this mixture was added to each of the four 
nucleoside phosphates at 37°C. After another 5 minutes, the reaction was stopped using 
5).11 of the provided stop solution. The samples were either checked immediately using 
gel electrophoresis or stored at -20°C until required. 
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2.9 Polyacrylamide sequencing gel electrophoresis 
In order to analyze the samples obtained from the sequencing reaction (described 
previously), a 6% polyacrylamide/urea sequencing gel was used. Prior to pouring the gel, 
the plates and chambers (Bio-Rad) were cleaned thoroughly with detergent, dH20, and 
ethanol to prevent the formation of bubbles. The apparatus was then assembled as 
described in the manufacturer's instructions. The gel was prepared with 80ml 
Sequencing Mix (40ml water, lOmllOXTBE, 48g Urea (Fisher), 15ml40% acrylamide), 
440J.tll0% ammonium persulfate (BRL), and 45J.1l TEMED (Bio-Rad). The solution was 
poured immediately and left to polymerize for at least 1.5 hours. 
Once the gel was set, it was pre-run in IX TBE at 60V for 30 minutes. The 
sequencing samples were denatured at ~85°C for 3 minutes and 3-6J.1l was loaded into 
each well. The gel was run at 60V usually until the dye reached the bottom of the gel. 
Following this, the gel was uncovered and fixed with 10% glacial acetic acid/10% 
methanol (Fisher). It was then dried under vacuum, packed with film, exposed overnight, 
and developed. 
2.10 RNA production 
To begin this procedure the plasmid DNA was first linearized with an appropriate 
restriction enzyme. Full-length Xmi-er 1 SP6 plasmid DNA was cut using Smal 
(Invitrogen). The Ribomax RNA Production Kit (Promega) was then utilized to make 
RNA from the linearized DNA 
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In this protocol, the four ribonucleotide phosphates were added to the DNA along 
with a customized buffer, cap analogue (New England Biolabs), and SP6 RNA 
polymerase. The components were mixed and incubated at 37°C for approximately 3 
hours. RQ1 RNase-free DNase (Promega) was then added to the reaction to digest the 
template DNA This was followed by a second incubation time of 15 minutes and a 
subsequent P:C:I 25:24:1 extraction in order to remove the enzyme. The RNA was 
precipitated overnight with 1/10 the volume of 3M sodium acetate, pH 5.2, and 2X the 
volume of95% ethanol, and washed repeatedly the next day using 75% ethanol. The 
fmal RNA product was then re-suspended in 50!-11 DEPC-treated dH20 and stored at 
-70°C until required. 
2.11 Ultraviolet spectrophotometry 
This method was used to determine the concentration of RNA and required the 
use of an ultraviolet (UV) spectrophotometer. The UV light (260nm) was turned on 30 
minutes prior to use in order to properly warm up the apparatus. Quartz cuvettes were 
rinsed and filled with dH20 to calibrate the machine. 11-11 of sample was then combined 
with 300!-11 of dH20 and placed inside the spectrophotometer (1 in 300 dilution). The 
reading was recorded once any fluctuations stopped (after -5 seconds). Another 300!-11 of 
dH20 was added to this and a second reading was taken and recorded (1 in 600 dilution). 
This process was then repeated for all samples. 
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2.12 Spectrofluorophotometry 
This method was used in conjunction with the Ribogreen RNA Quantitation 
Reagent and Kit (Molecular Probes) to determine the concentration of RNA The 
Ribogreen reagent is an ultra-sensitive fluorescent nucleic acid stain that can be used for 
quantitating in vitro transcribed RNA in solution. The RNA concentrations that were 
obtained from this method were compared with those obtained by UV absorbance 
(above) to ensure the accuracy of the results. The reasoning behind this is that the 
presence of free nucleotides in a solution (often resulting from the nucleic acid 
preparations) has the ability to skew the UV absorbance readings, causing the 
concentrations calculated to be incorrect. The use of a more sensitive nucleic acid stain 
(such as Ribogreen) overcomes this problem. When a discrepancy between the two 
systems existed, the concentrations calculated from the Ribogreen method were 
considered to be the more accurate result. 
The Ribogreen RNA Quantitation Kit provides the user with the fluorescent 
nucleic acid stain, as well as a ribosomal RNA standard. The f1rst step involves the 
creation of a standard curve using the provided RNA in order to relate the 
spectrophotometer readings of the unknown samples with the actual concentration of 
RNA (known). In the second step, the spectrophotometer readings are recorded for the 
unknown RNA samples. The concentration of the unknown samples can then be 
determined from the standard curve created in step one. 
Using the RNA sample stock, five different dilutions were made for generating 
the standard curve. Unknown sample RNA was diluted 10 000 fold. Dilutions were 
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done in a combination of TE Buffer and Ribogreen reagent. Spectrofluorophotometer 
(Shimadzu; model RF-1501) readings were then taken and recorded according to the 
following procedure. Cuvettes were first rinsed thoroughly with dHzO. Next, excitation 
. 
and emission values were set to 480nm and 520nm, respectively. The entire sample 
(2ml) was then transferred to the cuvette, which was placed inside the machine. Once the 
cover was closed, a timer was started. After 45 seconds, the shutter was opened in order 
to obtain the reading, and 15 seconds after that the reading was recorded to allow for any 
fluctuations in the initial value to settle. The shutter was once again closed and the 
sample was removed. This was then repeated for the remaining samples. 
2.13 RNA translation 
In order to ensure that the RNA used for injection could be translated into protein 
efficiently, an in vitro translation was performed using the TnT® Couple Reticulocyte 
Lysate System (Promega) prior to conducting any injection experiments. Before 
beginning, all components of the kit were thawed at room temperature and stored on ice. 
Once thawed, they were used to prepare a master mix that would be equally distributed to 
all samples. The reaction components were as follows (the first four were provided in the 
kit): Rabbit Reticulocyte Lysate, Reaction Buffer, Amino Acid Mixture minus 
methionine, RNAguard, [35S]-methionine, lJ..lg RNA template, and DEPC-treated d.H20. 
This was gently mixed by pipetting up and down, and then added to each sample. The 
remaining quantity of master mix was used as a negative control for translation. Next, 
the reaction was incubated for 90 minutes at 30°C. After this, the translation was 
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complete and the results could be analyzed. If analysis was done immediately, samples 
were stored on ice. If not, they were stored at -70°C until required. 
In order to perform the protein analysis, two different methods were employed 
and used in conjunction with one another. In the first, a portion of the sample was 
submitted for radioactive counts. This provided a numerical value for the amount of 
protein made by each sample based on the amount of e5S]-methionine incorporated into 
the protein. In the second method, the translated RNA was run on a 10% protein gel in 
order to visualize the results. 
Prior to doing the radioactive counts, 2J.tl of the TnT® sample was bleached with 
1M sodium hydroxide and 2% hydrogen peroxide (Fisher) at 37°C for 10 minutes or until 
the colour disappeared. The samples were then put directly on ice and combined with 
25% trichloroacetic acid (TCA; Fisher) I 2% casein amino acids (Merck). This was left 
to precipitate on ice for 20 minutes. lml of each sample was run through a filter using a 
vacuum flask and washed with 5% TCA and 95% ethanol, both of which were kept ice 
cold throughout the procedure. Next, 5ml of Biodegradable Counting Scintillant 
(Amersham) was added to each filter, and the vials were immediately placed in the 
scintillation counter to be read. Results were recorded and analyzed. 
For the second method, an additional2J.tl of the TnT® sample was combined with 
28J.tl of 1.5X SSB and run on a 10% SDS-PAGE gel at 30mA for approximately 1.5 
hours. The gel was then fixed and destained (Table 2.9) for 15 minutes each, and placed 
in Amplify (Amersham) for 30 minutes. Following this the gel was dried and exposed to 
Kodak XAR Scientific Imaging Film (Amersham) for visualization. 
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Table 2.9 Composition of Fix and Destain solutions 
Fix (ml) Destain ( ml) 
Methanol (Fisher) 45 20 
Glacial Acetic Acid (Fisher) 10 6 
dH20 45 74 
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2.14 Protein extraction 
In order to ensure that the various RNA constructs injected into embryos were 
being made into equivalent amounts of protein, total protein was extracted from the 
embryos and analyzed for the presence ofXMI-ERl. For each RNA set, 35 embryos 
were injected in the marginal zone at the 2-cell stage beside the cleavage furrow with lng 
of RNA and left to develop at room temperature. At stage 8.5, once the embryos had 
passed the mid-blastula transition, five embryos from each group were .placed in a petri 
dish. Using forceps, the vegetal pole was removed and discarded and the animal poles 
were placed in a 1.7ml tube with 175J.!ll.5X SSB (without bromophenol blue) and 
immediately homogenized. After 20 minutes on ice, the samples were centrifuged at 
lOOOOg for five minutes at 4°C. The middle layer containing the proteins was then 
removed using a lml syringe and frozen at -80°C until required. If the middle layer was 
cloudy upon removal, the layer was spun again and the middle layer removed a second 
time. This procedure was followed by Western Blotting to allow for protein 
visualization. 
2.15 Western blotting 
The Western Blot technique uses antibodies to bind to a desired protein, which 
enables the visualization of the protein. It was used here in order to confirm that the 
XMI-ERI constructs injected into embryos were being made into equal amounts of 
protein thus allowing the resulting embryos from each injection set to be compared. Prior 
to loading the extracted protein on a gel, the amount of total protein was measured to 
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ensure equal loading of protein. These measurements were completed using the Bio-Rad 
Protein Assay (Bio-Rad). 
The Bio-Rad assay is a procedure for determining the concentration of protein in 
a sample by adding an acidic dye to the sample, measuring it with a spectrophotometer, 
and comparing the readings with a standard curve. To create the standard curve, a set of 
serial dilutions was made from a Img/ml stock ofBSA. The absorbance of these samples 
at 595nm was then measured and graphed. Following this, IJ.tl of the unknown protein 
samples was diluted in 799J.1l.of d.H20 and 200J.1l of dye. Using the spectrophotometer 
results and the standard curve, the concentrations of the isolated samples were 
determined. 
Based on these calculated concentrations, the samples were diluted using I.5X 
SSB with bromophenol blue dye (BDH) and a total of 40J.lg protein was loaded onto an 
8% polyacrylamide gel. The gel was run for I.5 hours at 30mA in order to separate all 
the components. Once complete, the protein was transferred to a Hybond-ECL 
nitrocellulose membrane (Amersham) using the Bio-Rad Western Apparatus. The 
transfer was carried out over I.5 hours at 60V from the negative to the positive electrode. 
After the procedure was complete, the nitrocellulose membrane was placed in a 
blocking solution of 5% powdered milk (Carnation) in IX TBS-T (Table 2.IO) for I hour 
with slight agitation in order to block all of the non-specific binding sites on the 
nitrocellulose membrane. Following this, the membrane was transferred to a solution of 
IX TBS-T and stored overnight at 4°C. 
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The next day, the liquid was poured off and the membrane was placed directly in 
a 1 in 5000 dilution of the primary antibody (anti-MI-ER1) (Paterno eta/., 1997). It was 
incubated there for 1 hour, and washed every 10 minutes for the next hour with 1 X TBS-
T. After this, the secondary antibody (HRP-labelled donkey anti-rabbit; Amersham) was 
applied, again in a 1 in 5000 dilution. It was incubated for 1 hour, followed by another 
hour of 10-minute washes in 1 X TBS-T. At this point, the proteins were ready to be 
detected using the reagents supplied by the ECL (Amersham) detection kit. This step 
involved incubation for 1 minute in equal volumes of the two supplied reagents. The 
liquid was then poured off and the membrane was wrapped in plastic and immediately 
exposed to ECL Hyperfilm. Exposure times ranged from 10 seconds to 1 minute. The 
membrane was stored at 4°C in 1X TBS-T + 0.02% azide for further analysis. 
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Table 2.10 Composition ofTBS-T 
lX (in 4L) Final Concentration 
(ml) 
Tris pH 7.6 (Fisher) 80 20mM 
NaCI (Fisher) 109.6 137mM 
Tween-20 (Bio-Rad) 4 0.1% 
dH20 3806.4 N/A 
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2.16 Non-denaturing protein gel 
This technique was used to compare the behaviour of the constructs analyzed in 
an attempt to identify whether the differences observed with the embryo injections could 
be explained by varying protein confrrmations (Berrada et al., 2002; Zhang et al., 2003). 
Despite the fact that it is unclear whether XMI-ER1 itself dimerizes or not, any 
differences in this ability would nonetheless have been evident on a non-denaturing 
protein gel. To carry out this procedure, proteins that had been in vitro translated using 
the TnT® Kit (Promega) were run on a 5% acrylamide gel that had been pre-run at lOOV 
for 30 minutes prior to loading. Total running time was one hour and ten minutes, again 
at lOOV. Once completed, the gel was fixed and destained (Table 2.9) for ten minutes 
each using methanol, glacial acetic acid, and dH20. It was then placed in Amplify 
(Amersham) for 15 minutes and dried. The following day the proteins were visualized by 
autoradiography. 
2.17 Whole mount staining of X laevis embryos 
Whole mount antibody staining experiments were performed as described by 
Harland (1991), with some modifications. Embryos that had been previously stored at 
4°C in IX PBSA + 0.02% azide were transferred to 12-well culturing plates (Fisher) and 
washed in a solution of Maleic Acid Buffer (MAB; Table 2.11) for 10 minutes. This 
solution was then removed using suction and replaced with O.lM K2Cr207 (Fisher) in 5% 
Acetic Acid (Fisher) for 30 minutes. Following this, the embryos underwent three 10-
minute washes with MAB. Next, they were placed in 5% hydrogen peroxide (Fisher) in 
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MAB and were stored directly under a lamp for approximately 90 minutes until all 
structures including the eyes became bleached. Once this occurred, the embryos were 
washed once more with MAB and transferred to 2% Boehringer Mannheim Blocking 
Buffer (BMB) for 1 hour. The primary antibody was then added as a 1/1000 dilution in 
2% BMBIMAB for the 12/101 antibody and a 1/5 dilution for 2G9. The plates were 
stored at 4°C overnight. 
The next day, the embryos were washed every half hour for five hours with MAB. 
At the end of this second day, the secondary antibody, an alkaline phosphatase goat-anti-
mouse antibody (AP-GAM; Amersham), was applied as a 1/1000 dilution. The plates 
were once again stored at 4°C overnight. On the third day, the embryos were washed 
every hour for at least five hours using MAB and stored overnight at 4°C. On day four, 
the BCIP/NBT (Roche) visualization reaction was used. First the embryos were washed 
twice with AP buffer (Table 2.12) for ten minutes each. Following this, 90J.Ll NBT and 
70J.Ll BCIP were diluted in 10ml AP buffer and added to each set of embryos. The colour 
reaction was left to develop in the dark at room temperature. After 40 minutes, or when 
the staining was strong enough, the buffer was removed and replaced with MEMF A in 
order to stop the reaction. The plates were then stored at 4°C until required for 
photographs. The MEMF A solution was replaced with MAB after approximately 24 
hours. 
In order to obtain good photographs of the stained embryos, they were cleared by 
placing them for five minutes in each of the following solutions: 100% methanol, 100% 
ethanol, and 50% ethanol: 50% BA:BB 1:2 (benzyl alcohol {Kodak}: benzyl benzoate 
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{Sigma}; Murray's Clearing Reagent). They were then moved to a 100% BA:BB 
solution and photographed for approximately one hour. After this, the embryos were put 
through the same clearing procedure except in reverse so that they ended up in a solution 
of methanol and were then transferred to 1 X PBSA + 0. 02 % azide for further storage at 
4°C. 
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Table 2.11 Components of Maleic Acid Buffer (MAB) 
In 1L 
Maleic Acid (Fisher) 11.6g 
NaCI(Fisher) 8.8g 
dH20 up tolL; pH to 7.5 
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Table 2.12 Components of Alkaline Phosphatase (AP) Buffer 
In 100ml Final Concentration (mM) 
1M Tris pH 9.5 (Fisher) 10ml 100 
1M MgCh (Fisher) 5ml 50 
1M NaCl (Fisher) 10ml 100 
Tween-20 (Bio-Rad) 500J,ll 0.1% 
Levamisole (Sigma) 0.024g 5 
dH20 -74.5ml N/A 
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2.18 Whole mount in situ hybridization 
This procedure was carried out as described by Harland (1991), with minor 
modifications. Stage 10.5 albino embryos that had been previously fixed in MEMF A for 
45 minutes and stored in IX PBSA were washed three times in 0.1% Tween-20/lX 
PBSA (PBSAT) for 20 minutes each. The solution was then replaced with 2.5).11 
proteinase Kin lOml PBSAT and left at room temperature for 8 minutes. Following this 
were three 5-minute washes carried out while rocking first with 5ml O.lM 
triethanolamine (TEA; Sigma) pH 7.8, then with 5ml O.lM TEA+ 12.5).11 acetic 
anhydride, and finally with an additionall2.5).ll acetic anhydride added. The embryos 
were rinsed twice for 5 minutes with PBSAT and fixed for 20 minutes in 4% 
paraformaldehyde in PBSAT. The fixative was removed with five PBSAT washes over a 
15-minute period. The embryos were then incubated in lml PBSAT and 200).11 
Hybridization Buffer(Table 2.13), followed by 10 minutes in lml ofHybridization 
Buffer at 60°C, and 6 hours at 60°C in lml of fresh Hybridization Buffer with shaking. 
After the incubation, the embryos were placed in lml of a digoxigenin-labelled Xbra 
RNA probe and kept overnight at 60°C while shaking. 
The probe was made previously by mixing approximately 2.5).lg oflinearized 
DNA template with O.IM DTT (Sigma), NTP mix including digoxigenin-labelled UTP 
(Boehringer Mannheim), RNA Guard (Pharmacia), Transcription Buffer (Promega), 
polymerase (Promega), and DEPC-treated dH20. The reaction mixture was incubated at 
37°C for 2 hours and then l).ll of lmg/ml RNAse-free DNAse I (Promega) was added. 
The mixture was incubated an additionall5 minutes at 37°C. Following this, 0.2M 
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EDTA (Fisher), 4.0M Liel (Fisher), and 100% 'ethanol was added for overnight 
precipitation at -20°e. The next day, the probe was centrifuged at 4°e for 5 minutes, 
washed with 70% ethanol, and dried. It was precipitated again at -20°e overnight with 
4.0M Liel and 100% ethanol, and once again centrifuged, washed, and dried as before. It 
was then re-suspended in Hybridization Buffer and stored at -70°e. 
On the second day of the hybridization experiment, the probe was removed from 
the embryos and stored again at -70°e and the embryos were incubated in fresh 
Hybridization Buffer for one hour at 60°e with shaking. There were then three washes in 
2X SSe (0.3M sodium chloride and 0.03M sodium citrate) and 0.1% Tween-20 for 20 
minutes at 60°e. This was followed by RNase A and RNase T1 treatment in 2X sse at 
37°e for 30 minutes. The embryos were washed with 2X SSe and 0.1% Tween-20 for 
10 minutes at room temperature, and then placed at 60°e in 0 .2X SSe and 0.1% Tween-
20 twice for 30 minutes each. Next, they were rinsed with MAB (Table 2.11) and 
blocked with 2% BMB for 1 hour. They were stored overnight at 4°e in 4ml BMB and 
2.67J..Ll anti-digoxigenin AP Fab fragments. 
The next day the embryos were washed every half hour for at least 4 hours with 
MAB. They were then rinsed four times with AP Buffer (Table 2.12) over a period of20 
minutes and placed in a solution ofNBT and BeiP in AP Buffer to stain in the dark for 
approximately 2 hours. Once the stain was intense enough, the reaction was fixed in 
MEMFA (Table 2.2) and the embryos were stored at 4°e until required. 
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Table 2.13 Components of Hybridization Buffer and Denhart's Solution 
Hybridization Buffer: 
In lOOml 
Formamide (Fisher) . 50ml 
20X SSC (3M NaCI, 0.3M Na citrate (Fisher)) 25ml 
lOOmg/ml Torula RNA (Boehringer Mannheim) lml 
SOX Denhart's Solution 2ml 
0.5M EDTA (Fisher) lml 
Heparin (Sigma) IOmg 
Tween-20 (Bio-Rad) lOOJ.!l 
CHAPS (Sigma) IOOmg 
DEPC-treated dHzO up to IOOml 
lOOX Denhart's Solution: 
In lOOml 
BSA (Sigma) 2% 
Ficoll (Amersham) 2% 
Polyvinylpyrrolidone (BDH) 2% 
3X SSPE (NaCl, NaH2P04(1-hO), EDTA) (Fisher) up to lOOml 
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Chapter 3: Results 
3.1 Over-expression of Xmi-erl affects embryonic development 
Xmi-erl cRNA was injected into the marginal zone of embryos at the two-cell 
stage beside the cleavage furrow. The embryos were left to develop for three days and 
subsequently scored alongside four different sets of controls that included two RNA 
controls, one water-injected set, and an uninjected group. The two control RNAs were P-
galactosidase (/3-gal) and Green Florescent Protein (GFP). They were used to measure 
the background levels of abnormalities and non-specific effects caused by the injection of 
RNA into developing embryos. These were injected at a concentration of 2ng each, 
which was the maximum RNA concentration used for the Xm i-er 1 injections. As well, 
the water control, which consisted of DEPC-treated dH20, served as a control for the 
injection itself, ensuring that abnormalities were not simply due to penetration by the 
needle nor to the increase in total volume of the embryo. 
Four different concentrations of Xmi-er 1 were injected (2ng, 1.5ng, lng, and 
0.5ng) over a series of at least 5 independent experiments. Approximately 30-50 
embryos were injected per condition in each experiment. Embryos were then scored for 
phenotypic abnormalities at stage 40 of development, which is about three days after 
fertilization. A large percentage of abnormal embryos were observed in the Xmi-er ]-
injected groups when compared with the four controls. It was also found that as the 
injected concentration of Xmi-er 1 was increased, there was a dose-dependent increase in 
the percentage of abnormal embryos that formed. As displayed in Figure 3.1, the 
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background levels of abnormality observed in the control embryos were 21% for both 
GFP and {3-gal, 9% for the water injections, and 11% for the uninjected embryos. 
Although injection of the control RNAs resulted in percentages that were slightly higher 
than the remaining controls, these values were still significantly lower than those 
obtained with equal amounts ofXmi-erl (87%). The dose-dependant increase in 
abnormalities observed withXmi-erl was not seen with the controls, which resulted in 
low levels of abnormality even at such a high concentration. The percentages of 
abnormality measured for the remaining Xmi-er 1 injections were 7 4%, 49%, and 33% for 
1.5ng, 1ng, and 0.5ng RNA, respectively. 
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Figure 3.1 Over-expression of Xmi-er 1 RNA causes abnormalities in embryos 
Embryos were injected with one of four concentrations of Xmi-erl RNA and compared 
witlr the following four controls: GFP RNA, P-gal RNA, DEPC-treated dH20, and 
uninjected embryos. Injections were carried out at the two-cell stage in the marginal 
zone beside the cleavage furrow, as described in "Materials and Methods". The embryos 
were then left to develop at room temperature for three days until they reached stage 40, 
at which point they were scored for any abnormalities regardless of severity. From this 
the percent abnormality was calculated based on the total number of surviving embryos, 
approximately 400-600 per sample. For theXmi-erl injections, 95% ofthe embryos 
injected survived, compared to 98% of the controls. Shown are the results from 5 
experiments for the two RNA controls, 21 experiments for the water-injected set, 18 for 
the uninjected embryos, and 15, 13, 13, and 14 for the 2ng, 1.5ng, 1ng, and 0.5ng sets, 
respectively. Adapted from Teplitsky eta/. (2003). 
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3.2 Xmi-er 1 phenotype includes both anterior and posterior abnormalities 
To investigate its biological activity, Xmi-er1 was over-expressed in X laevis 
embryos using microinjection techniques. Most abnormalities that resulted from these 
injections were situated along the anteroposterior axis and could therefore be graded 
according to the dorso-anterior index (DAI) (Kao & Elinson, 1988). They involved 
various truncations along the length of the tadpole with a wide range of severity, 
including strictly anterior abnormalities (DAI 3-4), strictly posterior abnormalities (DAI 
7-8), and abnormalities or truncations at both ends (DAI 2+7 combined). A 
representative photograph of each of these phenotypes is illustrated in Figure 3.2. As 
demonstrated, the 'abnormal anterior' phenotype appears to be the least severe and only 
causes a reduction or slight truncation at the head. Embryos exhibiting the other two 
phenotypes show significant shortening of the anteroposterior axis. It must be noted that 
a certain amount of variation was observed within each phenotype category. As well, 
each concentration of Xmi-er 1 resulted in the full range of phenotypes. Nevertheless, the 
proportion of only the 'abnormal anterior & posterior' phenotype, which was by far the 
most severe, varied with the concentration injected, while the proportion of the other two 
remained relatively consistent regardless of the amount ofRNA injected (Figure 3.3). 
The 'abnormal anterior' phenotype varied from 8% to18% and the 'abnormal posterior' 
phenotype only varied from 11% to 16% throughout the Xmi-erl injections. Figure 3.3 
displays the percentages of each phenotype present per concentration of Xmi-er 1 injected. 
It demonstrates that as the concentration of Xmi-er 1 was increased, the percentage of 
embryos with anterior and posterior abnormalities also increased from 10% for the 0 .5ng 
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injections to 61% for 2ng Xm i-er 1. 
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Figure 3.2 Phenotypic effects of Xmi-er 1 over-expression 
Embryos were injected at the two-cell stage with 1. 5ng Xm i-er 1 RNA and left at room 
temperature to develop until control stage 40. At this point they were fixed in MEMF A 
and photographed. The above photographs show the range of tadpole phenotypes 
observed uponXmi-erl injection. These include (from top to bottom) normal embryos, 
embryos with anterior truncations, those with posterior truncations, and embryos with 
truncations at both the anterior and posterior end. Adapted from Teplitsky eta/. (2003). 
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Figure 3.3 Percentages of abnormalities observed with Xmi-erl injections 
Embryos were injected with different concentrations of Xmi-erl as indicated and allowed 
to develop at room temperature until stage 40 alongside the four sets of controls. At this 
point they were fixed in MEMF A and scored according to the level of abnormality 
observed. Three categories were used for scoring these abnormalities, all of which were 
along the anterior-posterior axis: abnormal anterior; abnormal posterior; and abnormal 
anterior and posterior. 
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3.3 Over-expression of XMI-ERl adversely affects gastrulation 
Throughout the early cleavage stages, the injected embryos developed normally. 
However, by the time they became tadpoles the situation was quite different. In order to 
determine whether this change occurred early or late in development, the injected 
embryos were also scored on the day after fertilization (at or before stage 20 in the 
control sets). In doing so, it was observed tha~ gastrulation in a large number of these 
embryos was abnormal. In many cases, the blastopore remained open, often with a large 
number of loose cells protruding through it and surrounding parts of the already-
gastrulated embryo such that the embryos appeared white rather than the normal 
brownish colour. 
The graph in Figure 3.4 demonstrates that by the end of gastrulation almost all of 
the abnormal tadpoles that resulted from injection of Xmi-er 1 RNA had already begun 
their irregular development. The abnormality data collected at this stage includes all 
observed deformities, from the most severe to the least. The specific% abnormalities 
observed on day one were 91%, 75%, 42%, and 28% for 2ng, 1.5ng, 1ng, and 0.5ng of 
Xm i-er 1 RNA, respectively. In comparison, the percentage of abnormally gastrulated 
control embryos were 9%, 11%, 8% and 20% for the water-injected, uninjected, fi-gal, 
and GFP groups, respectively. For the 2ng and 1.5ng values, the percentage of abnormal 
embryos was actually higher on day one than at tadpole stage for Xmi-erl injections. 
This suggests that perhaps a certain number of embryos recover. One explanation for this 
is the fact that the percentage abnormality calculated on day one included all abnormally 
gastrulated embryos, from the most severe to the least. Thus, it is possible that a few 
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with only slight gastrulation defects did in fact recover over the three days. 
From these results it is evident that the phenotypes seen upon injection of Xmi-er 1 
are the result of events affecting normal gastrulation processes and are not initiated by 
problems in subsequent development. Perhaps the over-expression of Xmi-er 1. a 
transcriptional regulator, interferes with key signalling events in developing embryos and 
impairs morphogenic movements involved in gastrulation. 
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Fig~re 3.4 Over-expression of Xmi-erl causes embryos to gastrulate abnormally 
Embryos were injected with one of four concentrations of Xmi-erl RNA and compared 
with the following four controls: GFP RNA, fi-gal RNA, DEPC-treated dH20, and 
uninjected embryos. Injections were carried out at the two-cell stage and were located at 
the marginal zone beside the cleavage furrow, as described in "Materials and Methods". 
The embryos were then left at room temperature and scored for any gastrulation defects, 
from the most severe to the least, by control stage 20. These are reported above as the % 
of abnormally gastrulated embryos out ofthe total number of surviving embryos (n). 
Data was collected from 17 experiments for the 2ng and 1.5ng data, 16 for the 1ng set, 
and 14 for 0.5ng. With respect to the controls, the dH20 data is from 24 experiments; the 
uninjected value is from 19; and, each of the RNA controls are based on 6 experiments. 
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3.4 Whole mount antibody staining demonstrates that mesodermal and neural 
tissues still differentiate in truncated embryos 
To further analyze the defects caused by Xmi-er1 over-expression, whole mount 
antibody staining of neural and mesodermal gene markers was performed. This enabled 
the investigation of Xmi-er1 to focus specifically on tissue development in the whole 
organism. Thus, embryos injected with Xmi-er 1 were fixed at the tadpole stage and 
subsequently stained with two different antibodies. In this way, two distinct tissue types 
derived from separate germ layers were examined. As FGF is known to play a critical 
role in the development and maintenance ofmesode.rm (Amaya eta/., 1991; Isaacs, 
1997), and Xmi-er 1 was initially isolated as an early-response gene to FGF, mesoderm 
was one of the tissues analyzed. To accomplish this, the 12/101 monoclonal antibody 
was used. This antibody recognizes somitic mesoderm and would therefore clearly 
indicate the extent of mesoderm inhibition brought about by the over-expression ofXMI-
ER1 (Kintner & Brockes, 1984). By comparing the Xmi-er1-injected embryos with 
water-injected and uninjected controls, it was observed that muscle tissue development 
was reduced and disorganized but not altogether absent, even in the most severe Xmi-er 1 
phenotypes (Figure 3.5). 
In addition to its function in mesoderm development, FGF is also thought to play 
a role in the formation of the nervous system in X laevis (Kroll & Amaya, 1996). It is 
known to regulate the expression of caudal genes (Northrop & Kimelman, 1994 ), and in 
doing so it has a posteriorizing effect on the neural ectoderm during gastrula and early 
neurula stages (Cox & Hemmati-Brivanlou, 1995). For this reason, neural tissues were 
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also analyzed by this method. This was carried out using the second monoclonal 
antibody, 2G9. 2G9 is a pan-neural antibody and therefore assesses ectodermally-derived 
tissues and particularly neural differentiation (Jones & Woodland, 1989). A similar result 
was obtained for this antibody. Again, even in the most severely abnormal tadpoles, the 
neural tissue was reduced and disorganized but still present (Figure 3.6). 
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12/101 (mesoderm) 
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mi-erl 
Figure 3.5 Whole mount staining with the anti-muscle antibody 12/101 
Stage 40 embryos that had been previously injected with Xmi-er 1 or DEPC-treated dH20 
were fixed in MEMFA and stored in 1X PBSA +azide. The tadpoles were subject to 
whole mount antibody staining with the 12/101 monoclonal antibody, as described in 
"Materials and Methods". The above photographs are of cleared embryos and are 
representative of the results obtained from five separate experiments. Positive 12/101 
staining appears dark purple and can be seen in all embryos, even those with the most 
severe abnormalities (arrow). Each embryo is oriented with the anterior to the right and 
the posterior to the left. Adapted from Teplitsky et al. (2003). 
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Figure 3.6 Whole mount staining with the pan-neural antibody 2G9 
Embryos that had been previously injected withXmi-erl and DEPC-treated dH20 were 
fixed in MEMFA at control stage 40 and stored in IX PBSA +azide until required. The 
tadpoles were subject to whole mount antibody staining with the monoclonal antibody 
2G9, as described in "Materials and Methods". The above photographs are of cleared 
embryos and are representative ofthe results obtained from 3 individual experiments. 
Positive 2G9 staining of neural tissue appears dark purple and was observed in all 
embryos, even the most severe (arrow). Embryos are oriented with the anterior to the 
right and posterior to the left. Adapted from Teplitsky eta!. (2003). 
88 
3.5 Xmi-erl injections cause abnormal brachyury expression 
In an attempt to clarify the effects of Xmi-er 1 on gastrulation, an in situ 
hybridization experiment was performed using a digoxigenin-labelled brachyury (Xbra) 
RNA probe. Xbra is a transcriptional activator known to be essential for gastrulation 
(Conlon et al., 1996). During early gastrula stages, Xbra is normally expressed 
throughout the marginal zone, forming a ring around the embryo (Smith et al., 1991). As 
suggested by its expression pattern, this gene plays a critical role in mesoderm formation 
and therefore serves as a general mesodermal marker (Smith et al., 2000). Isaacs et al. 
found thatXbra expression in X laevis is regulated by eFGF (1994). AsXmi-er1 was 
initially isolated as a response gene to FGF, using Xbra was a logical choice not only to 
enhance our understanding of the gastrulation defects, but ofXMI-ER1 as a whole. 
In order to determine whether the gastrulation defects observed upon injection of 
Xmi-er1 were due to the abnormal expression ofXbra, albino embryos were injected with 
1.5ng of Xmi-er 1 at the two-cell stage so that a percentage abnormality greater than 50% 
would be observed. They were then left to develop overnight at 13°C. As a control, a 
second set of embryos was injected with DEPC-treated dH20. The following day, the 
embryos were once again brought to room temperature and subsequently fixed in 
MEMF A at stage 10.5. They were then subject to whole mount in situ hybridization 
(Figure 3.7). It was found that 59% of the embryos injected with Xmi-er1 had incomplete 
expression rings ofXbra, while only 3% of those injected with dH20 had incomplete 
rings (standard deviation values are 20% and 8%, respectively). The embryos with this 
incomplete staining showed large gaps in the Xbra ring, or in some cases the staining was 
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almost entirely absent. 
These results may serve as an explanation for the incomplete gastrulation 
movements observed uponXmi-erl injection, as embryos with inhibitedXbra expression 
are known to have gastrulation defects (Conlon et al., 1996). Furthermore, they may also 
explain the absence of posterior structures seen at the tadpole stage for some of these 
embryos, as Xbra is required for the formation of posterior mesoderm and axial 
development (Conlon et al., 1996). The results could shed some light on the anterior 
defects as well, because defects in gastrulation could impair the migration of the already 
reduced mesoderm cells towards the anterior pole thus causing truncations at the head 
too. 
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Figure 3. 7 Embryos injected with Xmi-er 1 show abnormal expression of Xbra 
Albino X laevis embryos were injected with 1.5ng of Xmi-er 1 or DEPC-treated dH20 
and fixed in MEMFA at stage 10.5. Whole mount in situ hybridization was carried out 
using a probe for Xbra. Digital photographs representative of the Xbra expression 
patterns observed are shown above for both injected sets. White arrows in the bottom 
photographs highlight gaps in Xbra expression pattern observed in 59% (n=20) of Xmi-
er J-injected embryos. These results are based on five independent experiments. Adapted 
from Teplitsky et al. (2003). 
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3.6 Over-expression of Xmi-er 1 inhibits in vitro mesoderm induction by FGF 
Due to the fact thatXmi-er1 was initially discovered in response to FGF-induced 
mesoderm induction, this phenomenon was revisited once a phenotype had been assigned 
to the gene upon up-regulation. Thus, in an attempt to define the activities ofXMI-ERI, 
its effect on mesoderm induction was next analyzed. 
Embryos were injected with Xmi-er 1 in the animal cap of each cell at the four-cell 
stage such that a total of 1.5ng was injected. This was done in order to increase the 
probability that the majority of the injection site was excised when caps were cut at stage 
8. As a control for induction, a second set of embryos was injected with DEPC-treated 
dH20. They were then left to develop at room temperature until stage 8. At this point, 
the animal cap was removed and placed in Xenopus FGF-2, a known mesoderm mducer. 
Four different concentrations ofFGF-2 were used for this experiment: 0.5ng/ml, lng/ml, 
2ng/ml, and 5ng/ml. A number of embryos in each experiment were also placed in 
NAM/2 + BSA as a negative control for mesoderm induction. The explants were left at 
room temperature for three days and then Scored for mesoderm induction. Scores were 
marked as positive if the explant elongated from its original ball-like shape and expanded 
to form a bubble. 
Preliminary experiments using only one concentration ofFGF-2 suggested that 
mesoderm induction was reduced in those embryos that had been injected withXmi-erl 
when compared with water-injected controls. It was therefore expected that if Xmi-er 1 
was a true inhibitor of mesoderm induction, then its inhibitory activity should be 
demonstrated at near-threshold levels ofFGF-induced mesoderm induction (lng/ml and 
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2ng/ml) but could be rescued at higher FGF concentrations. In fact, this is precisely what 
was found in six separate experiments, as summarized in Figure 3.8. Over-expression of 
Xmi-er 1 resulted in a lower percentage of induced explants when compared with the 
water-injected controls, and this induction level was dependent on FGF-2 concentration. 
The greatest differential occurred at 0.5ng/ml FGF-2, where only 19% of Xmi-er ]-
injected explants were induced compared to a 50% induction in the controls. When the 
FGF-2 concentration was raised to lnglml, 37.5% of those injected with Xmi-erl formed 
mesoderm, whereas 64% of the water-injected controls were induced. Likewise, at 
2ng/ml FGF-2, the difference between the two sets was 57% versus 87%, respectively. 
Yet, at the highest concentration ofFGF-2, no such difference was observed, as 92% of 
the Xmi-er ]-injected explants were induced, and a corresponding 90% of the water-
injected explants were also induced. Thus, the high FGF concentration alone was able to 
entirely rescue the effects ofXmi-erl over.:.expression, indicating that XMI-ERI in X 
laevis specifically inhibits mesoderm induction. 
As a whole, these results, which demonstrate a partial inhibition of mesoderm 
induction, are consistent with the observations made with the whole mount antibody 
staining showing a reduction of tissues rather than a complete lack of them. They also 
agree with theXbra in situ hybridization data, which establishes that XMI-ERl interferes 
with Xbra expression but does not completely abolish it. Similarly, Xmi-er 1 over-
expression also appears to reduce FGF-induced mesoderm induction, but again it does 
not appear to inhibit this event altogether. 
93 
100% 
90% 
80% 
70% 
J!l 60% c 
i 
II( 
w 
"§ 50% 
:I 
"1:1 40% 
.5 
30% 
20% 
10% 
0% 
Figure 3.8 
Control 0.5nglml 1ng/ml 2ng/ml 5ng/ml 
FGF Concentration 
Over-expression of Xmi-er 1 inhibits mesoderm formation at near-
threshold levels of induction by FGF 
Embryos were injected at the four-cell stage in the animal cap of each cell with a total of 
1.5ng Xmi-er 1 RNA or with DEPC-treated dH20. At stage 8, explants were cut and 
cultured in one of four different concentrations ofFGF or in the control medium which 
was NAM/2 + lmglml BSA. The explants were left to grow for three days and scored on 
the third day for mesoderm induction. The graph is based on six individual experiments 
and the percentage induction was calculated from the total number of explants induced to 
form mesoderm out of the total number of explants cultured (75 per sample). 
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3. 7 Activin-induced mesoderm induction is not inhibited by XMI-ERl 
In order to examine whether XMI-ERl acts as a general inhibitor of mesoderm 
formation or is specific to the FGF pathway, its activity was tested in conjunction with a 
. 
second mesoderm inducer, activin. Embryos were injected in the animal pole of each cell 
at the four-cell stage with 1.5ngXmi-erl or DEPC-treated dH20. These embryos were 
left to develop until stage 8 at which point explants were removed and cultured in one of 
five concentrations of activin for three days (O.Olng/ml, 0.025ng/ml, 0.05ng/ml, 
O.lng/ml, and 0.15ng/ml). The induction results are demonstrated in Figure 3.9. It was 
found that below the induction threshold for the controls, at O.Olng/ml activin, only 3% 
and 4% of water-injected and Xmi-erl-injected explants were induced, respectively. 
However, at the next highest concentration of activin, the 0.025ng/ml threshold, 96% of 
the control explants were induced compared to 86% of the Xmi-er ]-injected explants. At 
0.05ng/ml activin, the values were 77% for the controls and 61% for Xmi-erl. For the 
two upper concentrations, both sets had equivalent induction levels. Statistical analysis 
of the induction values observed at 0,025ng/ml and 0.05ng/ml activin demonstrated that 
there is no significant difference between the Xmi-er ]-injected sets and the controls. 
These results suggest that XMI-ERl does not play a role in the activin pathway. 
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Figure 3.9 
Control 0.01 ng/ml 0.025ngml 0.05ngml 0.1 ngml 0.15ngml 
Activin Concentration 
Over-expression of Xmi-erl does not inhibit mesoderm formation 
during activin-induced mesoderm induction 
Embryos were injected at the four-cell stage with 1.5ng Xmi-er 1 or with DEPC-treated 
d.H20. At stage 8, explants were cut and cultured in one of five concentrations of activin 
(listed above), or in NAM/2 + lmg/ml BSA as a negative control. Explants were scored 
three days later for mesoderm induction. The above results are based on seven separate 
experiments and the percentage induction was calculated from the number of explants 
induced to form mesoderm out of the total number cultured (approximately 35-45 per 
sample). 
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3.8 The proline-rich domain is critical to the development of the XMI-ERl 
abnormalities, while the SANT domain, ELM2 domain, and putative MEK 
phosphorylation site are not 
There are numerous functional domains present in the XMI-ERI protein. In order 
to investigate which of these are required for inducing the abnormalities seen upon 
injection of Xmi-erl into embryos, a number of constructs were created that had 
mutations at key amino acids within these domains (Figure 3.10). The purpose of 
creating these constructs was twofold: first, to identify which domains were essential for 
XMI-ERl protein function during early X laevis development; and second, to pinpoint 
the activity of these domains to specific amino acid residues within them. 
The domains investigated included the ELM2 domain, the SANT domain, a 
proline-rich motif, and a putative MEK phosphorylation site. The mutated amino acids 
were selected based on comparisons with the same domains in other proteins using the 
National Center for Biotechnology Information BLAST Network Service. The chosen 
residues were those that appeared to be the most highly conserved throughout evolution 
(i.e., in all types of organisms), which is suggestive of their significance to the activity of 
the domain in their respective protein. Generally, in a mutational analysis, one of two 
approaches can be taken: 1) the amino acids can be mutated to other amino acids; or, 2) 
they can be deleted entirely. In the first method, these new residues can be similar to the 
original in terms of acidity/basicity, size, polarity, and charge, or they may be completely 
different. No one approach is better than another. For this reason, both methods were 
applied in this study, and a variety of tactics were employed for the mutations. 
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Figure 3.10 Schematic demonstrating the putative functional domains in XMI-
ERl and the mutations made in each domain 
The above illustration summarizes the functional domains found in XMI-ERl (labelled 
on top), as well as the general location of the mutation-containing constructs made in four 
of the domains (labelled below the diagram). TheN-terminal domain consists of four 
regions of acidic amino acids. Located in the centre of the protein are the ELM2 domain 
and the corresponding ~175-23~LM2 construct. Towards the C-terminus is the SANT 
domain composed of three helices, labelled Hl, H2, and H3. The four constructs made in 
this region include 277W~A, 277W~G, 319W~A, and .6.292YGKDF. Following this is a 
putative MEK phosphorylation site (TDY), and the 346TDY -+ADF construct. Next is the 
proline-rich motif (designated PSPPP) thought to bind SH3 domains of other proteins. 
The construct in this domain is 365PS~AA. At the C terminus is a bonafide NLS (Post 
eta/., 2001 ). 
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The mutation in the ELM2 domain, named /1175"236 elm2, involved a deletion of the 
majority of this domain to see whether this region was required for XMI-ERI function. 
Those in the SANT domain, 319W~A, 277W~A, L1292YGKDF, and 277W~, encompassed 
a variety of approaches to mutational analysis. The former two were considered to be 
moderate mutations in that a large, bulky, non-polar residue (tryptophan) was replaced 
with a small, also non-polar one (alanine). One the other hand, the latter mutation was 
more disruptive because the non-polar tt)rptophan was replaced with a polar glycine, 
which is a suspected helix-breaker. With respect to L1292YGKDF, this construct involved 
a deletion of five highly conserved amino acids. Rather than deleting the whole SANT 
domain, it was hoped that this smaller deletion would accomplish the same goal of 
interfering with the SANT domain function without affecting the whole protein. The 
mutation in the proline-rich motif, 365PS~AA, was made in these two residues to disrupt 
the activity of this region. The proline is a critical residue for the consensus SH3 binding 
motif and the serine in this sequence has the potential to be phosphorylated. Therefore 
both were mutated. As well, the mutation in the putative phosphorylation site was 
346TDY ~ADF in an attempt to disrupt possible phosphorylation at the threonine and 
tyrosine by MEK. 
All of the mutations were made by site-directed mutagenesis of Xmi-er 1 eDNA 
After they were sequenced to confirm the presence of the desired mutations, the 
constructs were transcribed into RNA and then injected into X laevis embryos alongside 
wild-type Xmi-er 1. Due to the fact that wild-type Xmi-er 1 injections led to abnormal 
embryos, it was predicted that a successful mutation (i.e., one that obstructed the activity 
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of a required functional domain in XMI-ER1) would result in normal embryos. Thus, by 
interfering with the function of a particular domain, the activity of the protein itself 
would also be affected, which would in tum influence the abnormalities seen with the 
wild-type injections. This would indicate that the specific domain plays a role in that 
activity and that the mutated amino acids are integral to this role. 
All of the mutants caused abnormalities that were similar to those obtained for 
Xmi-er 1 injections except for the 365PS~AA mutant. For this latter construct, the percent 
abnormality was comparable to that of the control RNAs. The overall percentages of 
abnormal embryos observed with these injections are shown in Figure 3 .11. 
The specific percentages from 1ng to 2ng ranged from approximately 15% to 
100% for 277W-+A, 277W--,)(J, and 319W-+A. While these constructs were only analyzed in 
two experiments at most due to their failure to alter theXmi-er1 injection phenotype, all 
of the remaining constructs were injected over four or more separate experiments. The 
corresponding range of the percentage abnormality from lng to 2ng was about 36% to 
94% for !1175-236elm2, 346TDY-+ADF, and LJ.292YGKDF. As was the case for Xmi-er1, the 
injection of increasing concentrations of each of these constructs resulted in a dose-
dependent increase in the percentage of abnormal embryos. As each of these mutants 
gave phenotype results similar to Xmi-er 1 when injected, they did not appear to interfere 
with an active domain in the XMI-ERl protein. From this it can be inferred that the 
amino acids affected by these various mutations are not involved in mediating the effects 
seen in the Xmi-er 1 phenotype. 
This was not the case for the PXXP motif construct, pictured in Figure 3.12. The 
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percentage abnormalities observed for 365PS~AA were 17%,24%, and 15% at 2ng, 
1.5ng, and 1ng, respectively, compared to the RNA controls at 21%. Thus, the majority 
of embryos injected with 365 PS ~AA consistently developed normally, as observed in 2 
experiments for the 2ng injections and 6 or more experiments for the other sets. The 
abnormalities did not increase in a dose-dependent manner like those for Xmi-erl but 
stayed relatively constant and low, regardless of the amount of RNA injected. 
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Figure 3.11 365PS-+AA mutant highlights amino acids that are required for 
the development of XMI-ER1 abnormalities 
Embryos were injected with one of three concentrations of 346TDY--+ADF, 277W--+A, 
277W-+G, 319W--+A, JJ292YGKDF, JJ175-236elm2, 365PS-+AA at the two-cell stage in the 
marginal zone alongside Xmi-er I. After three days at room temperature, the stage 40 
tadpoles were scored for abnormalities. The above graph shows the percentage of 
abnormal embryos out of the total number of surviving embryos ( n, indicated above each 
bar). The results for 277W--+A, 277W-;)(], and 319W--+A are based on one experiment only 
with the exception of the 1.5ng data. which is based on two experiments. For 
346TDY --+ADF and iJ292YGKDF, the data is based on 5 experiments for the 1.5ng set and 
4 experiments for the other two concentrations. For iJ175-236elm2, the results are from 9 
experiments. The 365PS--+AA values are from 2, 6, and 8 experiments for the 2ng, 1.5ng, 
and lng sets, respectively. There is no data available for 277W-+G and 319W--+A at 2ng. 
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Figure 3.12 Embryos injected with 365PS-MA develop normally compared to Xmi-
erl-injected embryos 
Embryos were injected at the 2-cell stage with lng of 365PS~AA RNA and left at room 
temperature to develop until control stage 40. They were then ftxed in MEMFA and 
photographed. The above photographs demonstrate the phenotypes expressed by the 
majority of embryos over-expressing 365 PS ~AA compared to embryos injected with Xmi-
erl. 
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3.9 365P is critical for XMI-ERl effects on development, while 366S is not 
After discovering that the 365 PS -+AA mutation was able to knock-out the Xmi-er 1 
effect when injected into developing embryos, this construct was analyzed further to 
determine whether this was due to the proline residue, the serine residue, or to both. To 
do this, the following two additional mutants were made: 365 P-+A and 366S-+A. These 
were then injected into embryos and compared with both 365PS-+AA as well asXmi-er1. 
The percentage abnormality results observed in these experiments are displayed in Figure 
3.13, and photographs of the embryos are shown in Figure 3.14. 
The 365 P -+A construct led to results that were similar to 365 PS -+AA in that the 
percentage abnormality was low and remained constant regardless of the RNA 
concentration. Again, no dose-dependent increase was observed for these injections. 
The specific results for this construct were 20%, 21%, 19%, and 19% for 2ng, 1.5ng, 1ng, 
and 0.5ng, respectively. On the other hand, the 366S-+A results were 77%, 57%, 46%, 
and 35%, for 2ng, 1.5ng, lng, and 0.5ng, respectively, compared to 87%, 77%, 49%, and 
44% for the Xmi-er1 injections. Thus, it appears as though the 366S-+A mutation causes 
no deviation from the Xmi-er 1 results. 
The fact that the injection of both 365PS-+AA and 365P-+A caused the development 
of embryos with a phenotype different from those injected with Xmi-er 1 suggests that the 
domain in which these mutations are located is important for the proper functioning of 
XMI-ERl. Moreover, the results show that the presence of one specific proline in the 
region e65P) is integral to this activity while the adjacent serine is not e66S). It is 
therefore evident that the mutation in this first proline and not the serine is responsible for 
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the difference observed upon 365 PS -+AA injection when compared with Xm i-er I. 
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Figure 3.13 Over-expression of 365PS~AA and 365P~A has no effect when injected 
into embryos but 366S~A results in phenotype similar to that of wild-
type Xmi-er 1 
Embryos were injected with one of four concentrations of 365PS~AA, 365P~A. or 
366 S ~A at the two-cell stage in the marginal zone alongside Xm i-er 1 injections. After 
three days at room temperature, the stage 40 tadpoles were scored for abnormalities. The 
above graph shows the percentage of abnormal embryos out of the total number of 
surviving embryos for each set of injections (n, indicated above each bar). The number 
of experiments upon which this data is based is 2 for the 2ng injections, 6 for the 1.5ng 
set, 9 for the lng set, and 3 for the 0.5ng injections. The data for 365PS~AA at lng is 
based on 8 experiments rather than 9. 
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Figure 3.14 Phenotypic effects of over-expressing 365PS~AA, 365P~A, & 366S~A 
Embryos were injected at the 2-cell stage with one of 365P8-+AA, 365P-+A, or 3668-+A and 
left at room temperature to develop until control stage 40. They were then fixed in 
MEMF A and photographed. The embryos pictured were injected with 1.5ng 365 P8 -+AA, 
365P-+A, 3668-+A, or Xmi-erl. The above photographs demonstrate the phenotypes 
expressed by the majority of embryos in each group. Thus, 365 P8 -+AA and 365 P -+A gave 
mainly normal embryos while 3668-+A resulted in primarily abnormal embryos upon 
injection. 
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3.10 Injected embryos show similar levels'ofXMI-ERl protein expression 
In order to ensure that the observed phenotypic differences described above were 
not due to variations in the amount of protein being translated from each RNA, the total 
protein per embryo was extracted. Using Western Blot analysis with an anti-MI-ERI 
antibody, the expression levels ofXMI-ERl (and its mutants) were determined. It was 
found that the protein levels were equivalent for all constructs, as is demonstrated by the 
bands in Figures 3.15a and 3.15b. 
Thedatain(a)representsXmi-erl, 346TDY-+ADF, 319W-+A, 277W-+A, 
LJ292YGKDF, 277W-+G, and /::...175-236elm2. The comparable protein levels confrrm that the 
abnormal effects of injecting these RNAs were not caused by irregular protein 
expression, and were due to the constructs themselves. As a negative control for this data 
set, water-injected embryos were analyzed as well. Despite its known presence in the 
embryo at this time, endogenous XMI-ERI expression was not visible because its levels 
were too low to detect. 
Figure 3.15(b) shows the expression levels ofXmi-erl, 365PS-+M, 365P-+A, and 
366S-+A. Again, the protein levels for these constructs were similar. This implies that the 
development ofnormal tadpoles upon the injection of 365PS-+M and 365P-+A into 
embryos was not due to a lack of protein expression or to abnormal protein expression. 
Rather, these results demonstrate that normal tadpoles were able to develop despite the 
presence of excess 365PS--"'AA and 365P--"'A protein but could not do so with over-
expression of 366S--"'A or XMI-ERI. 
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Figure 3.15 Protein expression levels in injected embryos 
Embryos were injected in the marginal zone at the 2-cell stage with RNA, as specified 
below. Protein was extracted at stage 8.5 and subjected to SDS-PAGE and Western Blot 
analysis, as detailed in "Materials and Methods". Isolated protein was loaded onto a 10% 
protein gel. The western blots were stained using a 115000 dilution of the anti-MI-ER1 
antibody and a 1/5000 dilution of the secondary antibody. a) Embryos were injected with 
H 0 xm·-erl (wt) 346TDY-+ADF 319W-+A 277W-+A A292YGKDF 277W-+G or ~175-z, l ' ' ' ' ' ' 
236 elm2, as indicated. H20 was used as a negative control. b) Embryos were injected 
with H20, 365PS-+M, 365P-+A, 3668-+A, or Xmi-erl, as indicated. Adapted from 
Teplitsky et al. (2003). 
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3.11 The lack of effects seen with 365PS_,.AA and 365P_,.A injections are not due to 
differences in protein behaviour 
In order to further investigate the role of the first proline in the proline-rich 
domain ofXMI-ERI, a gel shift assay was performed. This was done to determine 
whether the absence of this residue or the p:resence of an alanine in 365 PS _,.AA and 
365P--+A caused any changes in the conformation of the protein (Berrada et al., 2002~ 
Zhang et al., 2003). To resolve this, the constructs were first translated in vitro and the 
resulting proteins were run on a 5% non-denaturing acrylamide gel (Figure 3.16). This 
technique was employed to reveal any major physical differences in the proteins that 
could affect how they run on a gel. Discrepancies would have been evident by a band 
shift on the gel. Nonetheless, as demonstrated in the figure, there were no differences 
observed in the proteins. Therefore, a conformational change for 365PS~AA and 
365P~A cannot explain the variations in the injection results obtained for these constructs 
when compared withXmi-erl. 
110 
1 2 3 4 5 
Figure 3.16 Migration of mutant and wild-type XMI-ERl on a non-denaturing 
protein gel 
Mutant and wild-type Xmi-er 1 RNA were translated into protein in vitro and loaded onto 
a 5% non-denaturing protein gel for analysis. All bands migrated the same distance 
indicating no changes in the overall structure of the constructs when compared with 
XMI-ERl. The negative control used was translation mix with no RNA added. The 
protein shown in each lane is indicated above. 
Ill 
3.12 FGF-induced mesoderm induction is inhibited by 366S.....,.A but not by 
36Sps.....,.AA or 36sp.....,.A 
As demonstrated, the Xmi-er 1 constructs involving the residues of the proline-rich 
motif did not affect the development of embryos into tadpoles when the first proline was 
mutated to an alanine. Thus, two of the constructs, 365P8-+AA and 365P-+A, had no effect 
on tadpole development, while the third one, 3668-+A, caused abnormalities similar to 
those resulting fromXmi-erl injections. The next step was therefore to· determine what 
effects these constructs would have on mesoderm induction in vitro. These could then be 
compared to the effects ofwild-typeXmi-erl in this assay. 
Embryos were injected in the animal pole of each cell at the four-cell stage either 
withXmi-erl, 365P8-+AA, 365P-+A, or 3668-+A such that the total concentration injected 
per embryo was 1.5ng. As a control, dH20 was also injected. These embryos were 
allowed to develop at room temperature until stage 8, at which point explants were 
removed from the animal poles and cultured in lng/ml FGF or in NAM/2 + BSA as a 
negative control. The results for this experiment are shown in Figure 3.17. The graph 
demonstrates that 365P8-+AA and 365P-+A resulted in induction levels of76% and 75%, 
respectively, compared to 76% for the water-injected controls. Furthermore, the induction 
level recorded for 3668-+A was 38%. This is similar to the percent induction observed for 
Xmi-erl (32%) reinforcing the observation that this construct fails to eliminate the effects 
ofXMI-ERl over-expression. Conversely, 365P8-+AA and 365P-+A do appear to knock 
out the inhibitory effect ofXMI-ERl on FGF-induced mesoderm induction, confirming 
the fact that the mutated proline common to both mutants is integral for this function. 
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Figure 3.17 366 S ~A shows inhibition similar to that of Xmi-er 1 during mesoderm 
induction by FGF, while 365PS~AA and 365P~A do not 
Embryos were injected at the four-cell stage in the animal pole of each cell with a total of 
1.5ng Xmi-erl, 365P8~M. 365P~A. 3668-+A, or with DEPC-treated d.HzO. They were 
left to develop until stage 8, at which point explants were cut and cultured in 1ng/ml FGF 
or in NAM/2 + 1 mg/ml BSA as a control. Explants were left to grow for three days and 
scored on the third day for mesoderm induction. The graph is based on 3 different 
experiments for the 365P8-+M and 3668-+A data, 4 experiments for 365P-+A, and 6 for the 
Xmi-er 1 and water sets. The percentage induction was calculated from the number of 
explants induced to form mesoderm out of the total number of explants cultured 
(indicated as n above each bar). 
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n=50 
Chapter 4: Discussion 
It is now well established that FGF signal transduction plays a critical role in the 
proper development and maintenance of mesoderm in the developing X laevis embryo 
(Amaya eta!., 1991; Amaya et al., 1993; Isaacs, 1997). The recent discovery ofMI-ER1, 
an immediate-early gene in the FGF signalling pathway, has revealed a possible key 
player in this event, although its exact function is still being uncovered. An 
understanding of its role during embryogenesis can therefore shed some light not only on 
the protein itselfbut also on the intricacies and carefully controlled details ofFGF 
signalling. In an attempt to enhance the understanding of the X laevis orthologue of mi-
er 1, this study of XMI-ERl was carried out using X laevis as a model system. 
Based on the work presented here, and on other studies performed in the 
laboratory, it is now clear that the over-expression of Xmi-er 1 in X laevis embryos causes 
them to develop abnormally. Results indicate that as the injected RNA concentration is 
increased, the percentage of abnormal embryos also increases. These abnormalities are 
manifested along the length of the anterior -posterior axis of the embryo and vary quite 
dramatically in their severity. They result in tadpoles with a truncated anteroposterior 
axis that appears to be shortened from either the anterior end, or the posterior end, or 
both. 
There is a possibility that the variations observed may be due at least in part to the 
techniques used. The injection of RNA may over time lead to partitioning throughout the 
embryo causing protein expression to be quite mosaic in nature, as has been demonstrated 
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by Amaya et al. (1991; 1993). The authors found that when embryos were injected at the 
two-cell stage with XFD, the dominant-negative FGF receptor, a wide range of 
phenotypes resulted. These included the most severe phenotypes possessing normal 
heads yet extreme trunk deficiencies, but less extreme and normal embryos were found in 
each experimental group as well (Amaya et al., 1991). This variability was attributed to 
the injection technique, which can lead to a non-uniform distribution of RNA and may 
account for the small percentage of normal embryos that were often obtained in each 
experimental group for Xmi-er 1 injections. Nevertheless, by acknowledging this 
limitation, it is still possible to view the overall effects of RNA over-expression on 
embryonic development. One method that could be employed in future studies of Xmi-
er 1 to overcome this limitation is the use of a co-injected RNA, such as (3-galactosidase, 
that can be visualized to determine the expression pattern. 
To account for the possibility that the observed effects of Xmi-er 1 over-
expression were merely due to the presence of added RNA or to the resulting increase in 
cell volume, two RNA controls were used in the injection experiments, as well as a 
DEPC-treated dH20 control. In addition to this, for each experiment a group of embryos 
that had not been injected were set aside and scored at the same time as the injected ones. 
This was to ensure that the effects seen were due to the expressed RNA and not the result 
of batch variation. By comparing the effects of the Xmi-erl injections with the controls, 
it was clear that the Xm i-er 1 abnormalities were specific. The percentage of abnormal 
embryos obtained for all concentrations of Xmi-er1 was significantly higher than those of 
each control, including the two RNA controls which were injected at 2ng each, the 
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highest concentration used for Xmi-er 1. This indicated that it was specifically the 
expression ofXMI-ERl that caused the abnormal development. Nevertheless, it should 
be noted that the embryos injected with 2ng of the RNA controls had a slightly higher 
percentage abnormality than the water-injected or uninjected controls. However, this 
difference was not shown to be significant by statistical analysis. As well, the values for 
the RNA controls were still significantly lower than the percentage of abnormal embryos 
resulting from the lowest Xm i-er 1 concentration. 
Two additional RNA controls were actually created in this project through the 
production of various XMI-ERl mutant constructs. These were located in the proline-
rich motif at the C-terminus and were named 365PS-+AA and 365P-+A. Injection ofthese 
RNAs consistently resulted in the development of normal embryos despite the fact that 
they were identical to XMI-ERl with the exception of one or two amino acids. This 
confirms that the effects ofXMI-ERl over-expression were specific. Subsequent 
investigations into the in vivo activity of Xmi-er1 will benefit from the existence of these 
constructs. 
The in-depth analysis of the phenotypic effects of Xmi-er1 over-expression 
demonstrates the importance of this gene in the development of both anterior as well as 
posterior structures. Yet, FGF signalling is known to function in the development of only 
posterior structures, as seen by the results of expressing XFD (Amaya eta!., 1991). One 
possible explanation for this is that Xmi-er1 acts in other signalling cascades aside from 
those triggered by FGF. Although many possible pathways exist, the only additional 
pathway tested in this study was activin. It was observed that the induction of mesoderm 
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in animal caps injected with Xmi-er 1 was not reduced when compared with controls. 
Thus, XMI-ERI does not appear to act in this pathway. Further analysis of its role in 
other pathways would have to be done to determine whether the activities ofXMI-ERl 
does in fact extend beyond the realm of FGF signalling. 
Although many other genes have been described that affect either anterior or 
posterior development when over-expressed, there are few genes known to result in 
truncations at both ends. Xcad3, which is one ofthese rare examples, belongs to the 
caudal family of genes, well known for their prominent role in posterior development. 
These genes lie downstream ofFGF signalling and upstream ofthe Hox genes (Isaacs et 
al, 1998), which function in the regulation of anteroposterior specification. The injection 
of Xcad3 mRNA into developing embryos produces tadpoles that look quite similar to the 
Xmi-erl phenotype displaying both anterior and posterior truncations (Pownall et al., 
1996; Isaacs et al., 1998). It would be interesting to see whether the expression of Xcad3 
and the Hox genes are affected inXmi-er1-injected embryos using RT-PCR. Preliminary 
results have already demonstrated that at least one gene from the Hox family, the 
posterior marker HoxB9, is down regulated in embryos over-expressingXmi-er1 
(Luchman, unpublished results). 
Although the effects observed for the Xmi-er 1 phenotype varied significantly in 
different embryos, as a whole this gene appears to be essential for a wide range of tissue 
types. As muscle, bone, cartilage, and blood vessels make up a large portion of the 
anterior and posterior structures, some tissues of mesodermal origin are likely to be 
dependent on XMI-ERI for proper development. Since the central nervous system also 
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makes up a significant part of the head, it is possible that some tissue of ectodermal 
origin may too be controlled by XMI-ERI activity during development. The association 
of both of these tissue types with Xmi-erl activity was confirmed by whole-mount 
antibody staining, which showed that muscle, as well as neural tissue, was reduced and 
disorganized in embryos injected with Xm i-er 1. Yet, even embryos with the most severe 
deformities, involving truncations of both the head and the tail, showed positive staining 
for both tissues analyzed. Thus, tissue differentiation was still possible in Xmi-er ]-
injected embryos. This observation was supported by the FGF mesoderm induction 
experiments, which demonstrated thatXmi-erl-injected embryos exhibited reduced 
mesoderm induction in vitro but that this process was not altogether inhibited. 
The fact that these tissues were not entirely absent from any of the embryos 
stained indicated that while XMI-ERI may play a role in their formation, it is not wholly 
responsible for it. Whether additional structures are also influenced by this protein has 
yet to be discovered and could be the focus of future studies. Additional antibodies could 
be used to focus in on other tissues using the same technique. As well, histological 
analysis could indicate the specific structures that are absent in the abnormal embryos 
and could connect XMI-ERI activity with these features rather than with the anterior or 
posterior ends as a whole. Further analysis of the dorsoventral pattern of the neural tube 
and notochord using histology could determine whether XMI-ERl-associated truncations 
arise from an interference with patterning along the anteroposterior axis, as problems 
with the establishment of dorsoventral polarity could cause similar anterior.truncations 
(Wallingford et al., 1997; Isaacs et al., 1998). Knowledge of the particular tissues 
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affected by Xmi-er I over-expression is key to understanding the role of endogenous 
XMI-ER1 and FGF during normal X laevis development. 
The investigation into precisely when Xmi-er ]-associated abnormalities begin 
revealed that embryonic development appears normal until soon after gastrulation. The 
percentages of abnormal embryos at this stage and at tadpole stages were almost identical 
for each RNA concentration injected. This suggests that the abnormalities observed in 
the tadpoles were the direct result of difficulties in development that occurred at or near 
gastrulation, though the exact timing of this disruption is unclear. One possibility that 
arises with abnormalities at this stage is that they are caused by interference with the 
convergent-extension movements that occur during gastrulation. Sokol found that 
overexpression of a dominant negative Dishevelled mutant in X laevis embryos caused 
severe posterior truncations in tadpoles and blocked convergent-extension in ectodermal 
explants (1996). With respect to XMI-ER1 overexpression, the fact that these 
movements are still observed in the presence of activin rules out the possibility of 
abnormal convergent-extension as the cause of the observed gastrulation defects. In 
order to confirm the precise start of injected XMI-ERI activity and further insight into 
what this activity entails, more studies would have to be done perhaps using its cellular 
localization and molecular markers as an indication of its effects. 
With respect to endogenous XMI-ERl, it is known that while the protein is 
present throughout early development, it does not go to the nucleus until MBT (Luchman 
et al., 1999), suggesting that this is when it becomes active as a transcriptional regulator. 
Based on this, it is therefore likely that the effects of Xm i-er I over-expression begin 
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when the protein undergoes nuclear localization and when its endogenous activity also 
begins, although it is still possible that XMI-ERl acts earlier in the cytoplasm. As FGF 
signalling is required for primary mesoderm induction (Amaya eta/., 1993), and XMI-
ER1 is thought to play a part in this event, an active role for this protein at MBT makes 
sense. Perhaps the results of this influence are not evident at the gross morphological 
level until gastrulation movements are well under way, suggesting that cellular motility 
may in some way be compromised. 
Moreover, in addition to the known role ofFGF during mesoderm induction, it 
has also been shown that FGF signalling during gas~lation is required for mesoderm 
maintenance (Kroll & Amaya, 1996). Experiments with transgenic frogs expressing 
XFD at this stage demonstrate that embryos develop abnormally due to the de-regulation 
of mesodermal markers despite the fact that mesoderm induction had occurred normally 
earlier on. Thus, it is also a possibility that XMI-ER1 acts during this period ofFGF-
regulated cellular activities. Numerous FGFs are expressed at this stage of development, 
including eFGF, FGF-2, FGF-3, and FGF-9 (reviewed in Isaacs, 1997), implying that 
signalling through the FGF receptor, and therefore a potential requirement for XMI-ER1, 
is a natural occurrence at this time. 
One of the mesodermal markers that is affected by the aforementioned experiment 
involving the de-regulation ofFGF signalling during gastrulation, is Xbra. Analysis 
reveals that its expression is completely lost by mid-gastrulation, and as a result embryos 
develop without a notochord or somites (Kroll & Amaya, 1996). Whole mount in situ 
hybridization experiments with embryos over-expressing Xmi-er 1 demonstrate that while 
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Xbra expression is not completely knocked out during gastrulation it is partially 
inhibited. Specifically, examination of its expression pattern at stage 10.5 in these 
embryos shows that there are gaps in its normally ring-like expression. By this stage in 
development, endogenous XMI-ER1 has been shown to be localized to the nucleus of all 
cells in the X laevis gastrula (Luchman et al., 1999), indicating that the injected XMI-
ERI should be active in the region of Xbra expression at this time. Thus, the activity of 
XMI-ER1 appears to have an effect on the expression ofXbra. 
Due to the fact thatXbra expression is not completely inhibited, this suggests that 
there must be additional regulators present in the embryo. The existence of a gap in Xbra 
expression within gastrulating embryos indicates that XMI-ER1 may be acting in a 
particular subset of mesodermal tissues regulated by FGF. Further investigation of the 
precise location of the Xbra gap would be required to make this conclusion. Pinpointing 
the exact site of the gap may also link this effect with the original Xmi-erl injection site, 
which was beside the cleavage furrow at the marginal zone and therefore either dorsal or 
ventral. Analysis of Xbra expression following injections that are ventral or dorsal only 
could provide further insight into the mechanisms involved in this suppression. 
Identifying the gap in Xbra expression as specifically dorsal could also determine the 
region of the Xbra promotor that is used by XMI-ER1 in regulating its expression. Using 
point mutations and deletion analysis, Lerchner et al. discovered two repressor modules 
within the Xbra promotor that regulate Xbra expression differently both spatially and 
temporally (2000). One was found to control expression in the marginal zone during 
early gastrulation, while the second was responsible for dorsal mesoderm and ectoderm 
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expression at mid-gastrula stages. IfXMI-ER1 repression of Xbra expression in solely 
dorsal in nature, then it is likely that it acts through this latter module of the promotor. 
This dorsal effect ofXMI-ER1 would explain many of the abnormalities observed both 
during gastrulation and subsequent development. 
A recent study by Hayata et al. (2002) analyzed the effect of over-expressing 
Mig30, an organizer-secreted protein, on Xbra expression. As with Xmi-er 1, they too 
observed a gap in the expression pattern. This was localized at the dorsal marginal zone 
in 86% of the embryos analyzed (n=14) at stage 10.5. They also found an inhibition of 
elongation upon treatment of animal caps with activin. The authors hypothesize that the 
down-regulation of Xbra impairs gastrulation movements such as those seen in activin-
treated animal caps. It is therefore possible that the same applies to Xmi-er 1. The 
problems observed during gastrulation may very well be related to the reduction of Xbra. 
This explanation could easily be extended to the FGF mesoderm induction results as well, 
as Xbra is a known immediate-early gene in this pathway. It could also explain other 
abnormalities caused by Xmi-er 1, such as the tissue reductions .found with 12/101, and 
ultimately the Xmi-er 1 tadpole phenotype as a whole. The elongation of the anterior-
posterior axis is dependent upon a series of coordinated cell movements (Park et al., 
2002) beginning at gastrulation. One possibility is that XMI-ER1 impedes these 
movements by interfering with signalling and repressing important genes, such as Xbra, 
that are required for proper gastrulation. Perhaps the anterior abnormalities observed in 
theXmi-er1-injected embryos result from interference withXbra signalling, which in tum 
affects gastrulation movements and prevents cells from migrating anteriorly. This, 
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together with the reduction in induced mesoderm seen with the animal cap assays can in 
fact explain the range of anterior-posterior abnormalities present in the Xmi-er 1 
phenotype. While the posterior development is inhibited due to a general reduction of 
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mesoderm induction and patterning, as explained by the induction assays as well as the 
whole-mount antibody staining, the anterior formation is affected not only by this 
reduction but also by the impaired gastrulation movements. This latter hypothesis could 
be tested using migration assays of individual mesodermal cells on a fibronectin substrate 
(Kwan & Kirschner, 2003). As well, the additional analysis of Xbra expression at stage 
12.5 could confrrm whether gastrulation movements are in fact slowed (Hayata eta/., 
2002). 
With respect to the aforementioned mesoderm induction experiments, the Xmi-
erl-associated reduction of induced mesoderm was observed at near-threshold levels of 
FGF only. By increasing the concentration ofFGF, the inhibiting effects ofXMI-ER1 
over-expression were rescued. This ultimately demonstrated that the inhibition of 
mesoderm induction seen withXmi-erl injections was reversible and therefore specific. 
While it was already known that XMI-ER1 acts in the FGF-signalling pathway, as it was 
initially isolated in response to FGF treatment in animal caps, these results further 
support a regulatory role for endogenous XMI-ER1 in this pathway during mesoderm 
induction in the embryo. 
Besides its role in mesoderm development, FGF is also thought to be involved in 
the formation of the nervous system (Kroll & Amaya, 1996), by regulating caudal gene 
expression (Northrop & Kimelman, 1994). This is thought to have a posteriorizing effect 
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on the neural ectoderm during gastrula and early neurula stages (Cox & Hemmati-
Brivanlou, 1995). To determine the full range of effects caused by Xmi-erl over-
expression, neural tissue was analyzed using the pan-neural antibody, 2G9. Results from 
these immunostainings indicated that while neural tissue was reduced and disorganized it 
was not absent. This lends itself to two possibilities: thatXmi-erl has a role in the 
neuralizing effects ofFGF, in addition to its part in mesoderm development; and/or that 
its effect on neural differentiation occurs through other signalling pathways aside from 
FGF. As Xmi-er 1 appears to regulate anterior as well as posterior development, while the 
effects of FGF seem to be limited to the posterior nervous system, the latter is a good 
possibility. To confrrm the function ofXMI-ERl in neural development and to isolate 
the signalling pathway(s) in which it acts, further experiments should be conducted, 
beginning with an analysis of neuronal markers in Xmi-er ]-injected embryos compared to 
controls. 
In order to identify the mechanisms by which XMI-ERl fulfills its functions 
during embryonic development, a number of the domains located within the protein were 
investigated by mutational analysis. Initially, the amino acid sequences of these domains 
were compared with similar sequences in other proteins that were found using BLAST 
searches. These were analyzed in order to detect specific amino acids that appeared to be 
highly conserved throughout evolution. However, due to the vast number of conserved 
residues that were highlighted through this process, and the time limitations associated 
with this project, not all of these sequences could be investigated. Thus, to a certain 
extent, the conserved regions of each domain had to be chosen somewhat arbitrarily. 
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Once these were selected, mutations were made at some of these key residues, and the 
developmental effects of injecting these constructs were compared with those from the 
wild-type Xmi-er 1 injections. 
The domains that were analyzed using this method included the SANT domain, 
the ELM2 domain, a putative MEK phosphorylation site, and a proline-rich region. It 
was expected that if these domains were involved in the activity of the injected protein 
during development, then the mutation of a critical amino acid within the domain would 
suppress or interfere with this activity. The subsequent injection ofanXmi-er1 construct 
whose function had been compromised was then expected to have no effect on embryonic 
development. 
Results from these injections yielded a number of interesting observations whose 
validity was confrrmed by Western Blot analysis showing similar levels ofXMI-ERl 
protein expression for all constructs. The deletion ofthe majority of the ELM2 domain in 
..1175-236 elm2, did not lead to the development of normal embryos. The tadpoles that 
developed when injected looked much like those resulting from wild-type Xmi-er 1 
injections. It can therefore be concluded that the deletion did not encompass amino acids 
that were essential to the activity of this domain~ or, that this domain was not involved in 
the events leading to the abnormal effects observed with wild-type Xmi-er 1 over-
expression. With respect to the former conclusion, it should be pointed out that at the 
time this deletion construct was made, the amino acids removed (aa 175-236) were 
thought to comprise the majority of this domain. It was not until after the experiments 
were completed that it was discovered in our lab that the ELM2 domain in XMI-ERl 
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actually includes more amino acids than initially thought and that this additional 
sequence C terminal to the domain is required for ELM2 and XMI-ERl activity (Ding et 
a/., 2003). For this reason, it would be interesting to see the effects of injecting an Xmi-
er 1 construct that had the whole of the ELM2 domain deleted to see if the results would 
be any different from those found here. Perhaps the additional residues are key to the 
function of this particular domain in XMI-ERl so that by deleting them as well or even 
on their own, the over-expression effects on embryos would be abolished. 
With respect to the second conclusion, it was recently found that within hMI-ERl, 
the human homologue ofXMI-ERl, the ELM2 domain is essential for the recruitment of 
HDACl, which is required to enable hMI-ERl to act as a transcriptional repressor (Ding 
et al., 2003). It therefore seems unlikely that two proteins that are so similar differ in this 
function that appears to be so essential. Nevertheless, it is a possibility. XMI-ERl is 
known to possess potent transcription transactivational activity (Paterno eta!., 1997) and 
is not known to function as a repressor (unpublished results). Perhaps this difference in 
transcriptional regulation accounts for the unexpected results observed upon injecting 
Ll175-236elm2 into embryos. Obviously to fully understand these results, more work needs 
to be done at this level. What can be taken from this, however, is the fact that the amino 
acids that were deleted in this region were not critical to the development of the 
abnormalities seen with the wild-type Xmi-erl injections. 
The second major domain that was tested was the SANT domain. This motif is 
often found in proteins that are involved in transcriptional regulation as well as in 
chromatin-regulatory complexes, and has some similarity to the DNA-binding domains 
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of myb-related proteins (Aasland et al., 1996; Sterner eta/., 2002). Recent studies also 
indicate that SANT -containing regions of a number of co-repressors, including CoRES T 
and SMRT, can bind and activate HDACs (Guenther eta/., 2001; You eta/., 2001). 
However, the exact function of the SANT domain in XMI-ERI is still unknown. 
Rather than performing a deletion of the whole domain, the SANT domain was 
analyzed for the most part using point mutations. In total, four constructs were used in 
the investigation of this domain. Two mutations were focused on the highly conserved 
tryptophan at the start of this region; one at a tryptophan located towards the end of the 
sequence; and the fourth was a deletion of five aminp acids situated between the first and 
second helices within the domain. One recent study focusing on the SANT domain of 
Ada2 found the first tryptophan residue to be essential to the function of this domain in 
the protein (Sterner eta/., 2002). Two of the four XMI-ER1 SANT domain constructs 
included mutations of this same amino acid. Sterner et a/. also demonstrated that the frrst 
half of the SANT domain in Ada2 could be directly linked to an interaction with or the 
recognition of chromatin (2002). In XMI-ER1, three of the SANT domain constructs can 
be mapped to this region, including 277W -+A, 277W -KJ, and L1292YGKDF. Nevertheless, 
injection of all four constructs yielded the same result. That is, like the ELM2 mutant 
discussed previously, they too caused the same defects seen with wild-type Xmi-erl 
injections. It therefore appears as though the mutations were not located in amino acids 
that were required for bringing about the abnormalities seen with Xmi-er I over-
expression, despite comparisons with other SANT domain sequences from other proteins. 
Similar results were obtained for injections of the construct containing the 
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mutated putative MEK phosphorylation site, a domain whose presence is predicted by 
numerous computer-assisted sequence analysis programs. Again, embryos developed 
abnormally and caused defects equivalent to those obtained for Xmi-er1 injections. Thus, 
despite the changes that were made in this domain, the effects of over-expressing this 
construct were no different from the effects of over-expressing the wild-type sequence. 
These results suggest that this putative phosphorylation site is not associated with the 
abnormalities caused by Xmi-er 1 over-expression, and may not be a true phosphorylation 
site. Supporting this idea is the fact that the XMI-ER1 protein has never been shown to 
undergo phosphorylation and instead seems to be associated with other phosphorylated 
proteins in both its cytoplasmic as well as nuclear states (Luchman, unpublished results). 
The fmal set of mutations were situated within the proline-rich motif located 
downstream of the SANT domain. In XMI-ER1, this is composed of the following 
sequence: PSPPP. Often, such regions are involved in binding SH3 domains of a protein 
that mediates interactions with a second protein. This binding would occur through one 
of the pro lines (Ren et al., 1993). However, the presence of a serine in this region made 
proline-directed phosphorylation another possibility. Investigation into the activity of 
this domain revealed that the proline-rich motif functions in the XMI-ER1 protein; that 
this region mediates the effects seen upon over-expressing wild-typeXmi-er1; and, that 
the activity of this region can be pinpointed to the first proline of this domain. 
Once this was observed, the activity of these proline-rich domain constructs was 
investigated further in comparison with wild-type Xmi-er 1. Analysis of the mesoderm 
induction activity for the proline-rich region constructs showed a similar reduction for 
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366S~A, which, like Xmi-eri, causes abnormalities in embryos. However, the remaining 
two constructs, 365PS--+AA and 365P--+A, did not inhibit mesoderm induction activity in 
the same manner. These results confirm that the proline-rich domain is critical to the 
formation of abnormalities seen with the over-expression of Xmi-er I in X laevis 
embryos. Further analysis of the effect these proline mutations have on the structure of 
the XMI-ERl protein would complement this functional data well. 
As for the future of this study, there is obviously a lot of work that has yet to be 
done in order to fully comprehend the role of Xmi-er I in developing X laevis embryos. 
Nevertheless, the elucidation of the effects that this gene has upon over-expression and 
some of the tissues this affects are significant endeavours. In terms of the next step, 
doing the reverse study by knocking out this gene using RNAi or morpholino antisense 
technology could prove to be very exciting. This, together with the over-expression data, 
would help explain the various activities of endogenous XMI-ERl in the embryo. 
Further analysis of the functional domains and the effects the protein has on additional 
gene expression and tissue formation would also be very valuable to the understanding of 
the FGF pathway in this organism. Analysis of molecular markers could paint a clearer 
picture ofXMI-ERl activity during development. The markers could be used to focus in 
on what is happening in the specific regions affected by Xmi-er I over-expression, such as 
otx2 andX!Hboxi for an anterior analysis, Xhox36 or Xhox3 for the posterior, and 
perhaps MyoD as a dorso-ventral mesodermal marker. As well, more work in this area 
could benefit current and ongoing studies ofhMI-ERl and its activity in human cancers. 
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